University of Kentucky

UKnowledge
University of Kentucky Master's Theses

Graduate School

2009

FURTHERING PHARMACOLOGICAL AND PHYSIOLOGICAL
ASSESSMENT OF THE GLUTAMATERGIC RECEPTORS AT THE
DROSOPHILA NEUROMUSCULAR JUNCTION
Junyoung Lee
University of Kentucky, c14586@gmail.com

Right click to open a feedback form in a new tab to let us know how this document benefits you.

Recommended Citation
Lee, Junyoung, "FURTHERING PHARMACOLOGICAL AND PHYSIOLOGICAL ASSESSMENT OF THE
GLUTAMATERGIC RECEPTORS AT THE DROSOPHILA NEUROMUSCULAR JUNCTION" (2009). University
of Kentucky Master's Theses. 619.
https://uknowledge.uky.edu/gradschool_theses/619

This Thesis is brought to you for free and open access by the Graduate School at UKnowledge. It has been
accepted for inclusion in University of Kentucky Master's Theses by an authorized administrator of UKnowledge.
For more information, please contact UKnowledge@lsv.uky.edu.

ABSTRACT OF THESIS

FURTHERING PHARMACOLOGICAL AND PHYSIOLOGICAL ASSESSMENT
OF THE GLUTAMATERGIC RECEPTORS AT THE DROSOPHILA
NEUROMUSCULAR JUNCTION

Drosophila larval neuromuscular junctions (NMJs) serve as a model for synaptic
physiology. The molecular sequence of the postsynaptic glutamate receptors has
been described; however, the pharmacological profile has not been fully
elucidated. Despite the postsynaptic molecular sequence used to classify the
receptors as a kainate subtype, they do not respond pharmacologically as such.
Kainate does not depolarize the muscle, but dampens evoked EPSP amplitudes.
Quantal responses show a decreased amplitude and area under the voltage
curve indicative of reduced postsynaptic receptor sensitivity to glutamate
transmission. ATPA, a kainate receptor agonist, did not mimic kainate’s action.
The metabotropic glutamate receptor agonist t-ACPD had no effect. Domoic acid,
a quisqualate receptor antagonist, blocks the postsynaptic receptors without
depolarizing the muscle, which supports the presence of quisqualate subtype
receptors. The results suggest a direct postsynaptic action of kainate due to
partial antagonist action on the quisqualate receptors. There does not appear to
be presynaptic auto-regulation via a kainate receptor subtype or a metabotropic

auto-receptor. A complete pharmacological profiling of the known receptor
subtypes at this NMJ has not yet occurred; however, this study aids in furthering
the ongoing investigations to provide a clearer picture of pharmokinetic profile
and specificity of the receptor subtypes.
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Chapter One
Background of the Drosophila neuromuscular junction and research goals

The nervous system in animals is used to convey information of the
surrounding external and internal environment, as well as to react to it. In the
majority of cases, the electrical signals neurons use are relayed to target cells by
chemical communication. When this occurs for close targets, the site of
communication is referred to as a synapse. The chemical released from the
presynaptic neuron is referred to as transmitter. This transmitter enters into the
synaptic cleft and then binds to receptors on a target cell. The target cell can be
a neuron, a muscle or an endocrine cell or even a combination of cell types. The
post-synaptic receptors determine if the target cell will be excited or inhibited.
These determine actions by the receptor itself, being a ligand-gated ion channel
or by initiation of a cellular cascade to influence ion channels (Berridge, 1998;
Miyazaki, 1995). Receptors that mediate secondary cascades are referred to as
metabotropic receptors, whereas receptors that act as a receptor mediated ion
channel are termed ionotropic receptors.
The neurotransmitter molecules are stored in vesicles within the presynaptic
nerve terminal. These vesicles fuse to the presynaptic membrane with evoked
stimulation because of the rise in [Ca2+]i (Sudhof, 2004). The [Ca2+]i is generally
very low compared to that outside the neuron ( [Ca2+]o is 10 mM). The entry of
Ca2+ into the nerve terminal causes the mobilization of both the reserve and the
readily releasable pools of vesicles (Rosenmund and Stevens, 1996; Kuromi and
Kidokoro, 1998).
The whole process of vesicle fusion must be finely regulated as not to over or
under excite the target cells or else the information will not be correctly
conveyed. Thus, there are various levels of excitation and inhibition to regulate
nerve terminals, such as ion pumps, ion exchanges and auto-receptors for
negative feedback. Because of the difficulty in accessibility of postsynaptic
dendrites and the wide complexity of the central nervous system in general, most
of our understanding in synaptic properties at a vesicle level (i.e., quantal level)
has been gained by studying accessible and relatively simple preparations, such
as neuromuscular junctions (NMJ) in invertebrates and amphibians (Bennett and
Pettigrew, 1975; Nudell and Grinnell, 1983; Wilkinson and Lunin, 1994; Wilkinson
et al., 1992). The frog, locust and crayfish neuromuscular junctions were initially
used because of the relatively ease for accessibility and viability in relatively
mimimal physiological salines (Fatt and Katz, 1953a, b; Dudel, 1965, 1981;
Dudel et al., 1983).
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More recently the Drosophila melanogaster has become a model for synaptic
transmission at the larval NMJ. This is because a known genome that can be
manipulated for altered protein expression to examine mechanistic cellular
functions of synapses (Atwood et al., 1993; Betz et al. 1993; Jan and Jan 1976;
Kurdyak et al., 1994; Li et al., 2002; Li and Cooper, 2001; Pawlu et al., 2004;
Ruffner et al., 1999; Sigrist et al., 2002, 2003; Stewart et al., 1994, 1996). A
recent review in Ca2+ regulation which influences synaptic transmission in the
preparation has appeared (Desai-Shah and Cooper, 2009).
Since the larval Drosophila NMJ is becoming a synaptic model of choice
recently for many reasons, it is important to understand the pharmacological and
physiological profiles of this synapse. The Drosophila NMJ consists of excitatory
motor neurons and muscle. Recent studies described which postsynaptic
receptor subtypes are expressed in muscle. There are five different subunits,
which fall into kainate/AMPA type glutamate receptors based on molecular
sequence homology (Betz et al., 1993; Völkner et al., 2000; Marrus et al., 2004;
Qin et al., 2005; Guerrero et al., 2005). However, in an experiment investigating
a pharmacological sensitivity on the postsynaptic receptors for intact 3rd instar
Drosophila NMJ, kainate did not depolarize the muscle but reduced the EPSP
amplitude. Also, AMPA did not alter the EPSP amplitude nor alter the resting
membrane potential (Bhatt and Cooper, 2005). Thus, the postsynaptic receptors
at the Drosophila NMJ should not be classified based on a pharmacological
profiling nomenclature as a kainate/AMPA subtype of glutamate receptors.
Based on my investigations and the previous study (Bhatt and Cooper, 2005),
kainate appears to be blocking the glutamate activities at the larval Drosophila
NMJ.
To date, the pharmacological assessment of this NMJ has not been
tackled carefully. No one has even addressed if the motor nerve terminals may
possess glutamate auto-receptors as noted to occur in other arthropod species
(Schramm and Dudel, 1997). Thus, I choose to address these issues in my
studies.
In this research project, I first support the idea that the postsynaptic receptors
at the Drosophila NMJ are not of a kainate subtype of glutamate receptors and
that application of kainate reduces the evoked EPSP amplitude. I approached
these studies by use of pharmacological and physiological investigations.
Specifically I addressed the spontaneous vesicular postsynaptic responses at the
3rd instar NMJ using domoic acid and glutamate. Domoic acid is a potent agonist
of the kainate subtype of glutamate receptors in vertebrates. I also addressed
how exogenous application of kainate could be causing the reduction of the
EPSP amplitudes.

The hypotheses I am testing is based on preliminary findings at this
NMJ and combined reports on other glutamatergic synapses in various animal
2

models. The hypotheses addresses why kainate produces a reduction in the
EPSP amplitude. My hypotheses are as following;
1) Kainate has a direct postsynaptic action as an antagonist.
2) Kainate has a direct presynaptic action reducing glutamate release,
possibly through activating glutamatergic autoreceptors on the nerve terminals.
Addressing these aims is very important in understanding processes in
synaptic regulation at the neuromuscular junction of this model preparation.
Several disorders are known for altered synaptic function in the vertebrate brain.
In order to understand these disorders better, one can use invertebrate models
such as Drosophila, which can serve as good electrophysiological and genetic
models to study synaptic regulation on a fundamental level.
In order to elucidate my hypotheses about kainate’s action at the
Drosophila NMJ, I conducted several experiments as described in detail within
Chapter Two. In short, I examined the action of kainate on spontaneous fusion of
vesicles with exposure to kainate. This is diagrammatically shown in Figure 1-1
with kainate either having an action on the presynaptic terminal or having an
action on the postsynaptic receptors as to alter receptivity to glutamate. Since
[Ca2+]i is tightly regulated within the nerve terminal for rapid transmission, if
kainate had a presynaptic action via alteration in the [Ca2+]i , I would predict that
short-term facilitation or depression, known to occur at this synaptic preparation,
would be greatly affected. Thus, I used a four-pulse stimulation train and
measured the facilitation index before and during application of kainate at various
concentrations of kainate as well as [Ca2+]o. Since transmission is so sensitive to
[Ca2+]o altering the concentration with various concentration of kainate exposure
might unmask any subtle effects of kainate. This general model to address this
experimental paradigm is shown in Figure 1-2. In addition to the action of kainate
other pharmacological agents were examined to help in describing the
pharmacological profiles of the putative presynaptic and known postsynaptic
glutamatergic receptor subtypes. The working models of action for ATPA (Figure
1-3) and t-ACPD (Figure 1-4) are shown for action on evoked transmission.
In addition, the reports which characterized the molecular sequence of the
glutamate receptors at the Drosophila NMJ to the human’s kainate receptor
subunits, did not provide the statistical similarities between them. The paper
published in 2005 by Qin et al., designated some amino acid sequences as
similar even though they appear to be far from being similar. Besides, in this
earlier study only five amino acid sequences of the postsynaptic receptor
subunits at the Drosophila NMJ were examined although there are around 30
different glutamate receptor genes in Drosophila genome (Littleton and Ganetzky,
3

2000). Thus, I show statistical similarities of the aligned sequences (Figure 15a,b) and provide a phylogeny tree with the known 36 predicted amino acid
sequences of the glutamate receptors in Drosophila genome (Table 1-1).

4

Figure 1-1. Schematic model of predicted kainate action at the Drosophila
neuromuscular junction, which is the site of communication from the axon
terminal of motorneuron to the muscle. Kainate is added into the synaptic cleft
without neural stimulation to measure any possible direct effect on either the
presynaptic nerve terminal or on postsynaptic sensitivity. Spontaneous
responses are involved in one vesicle fusion events. If kainate has an effect
presynaptically then one would expect an alteration in the frequency of
spontaneous response. If there was an affect on the postsynaptic receptors then
one would expect a change in the amplitudes or shape of the spontaneous
events. The frequency and amplitude of spontaneous responses before and
during exposure to kainate are compared.
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Figure 1- 3. Schematic model of predicted ATPA action at Drosophila NMJ.
(RS)-2-Amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl)propanoic acid (ATPA) is a
kainate receptor agonist. If ATPA has an action either presynaptically or
postsynaptically it would alter the frequency of amplitude of spontaneous events
and the size of evoked responses. Excitatory postsynaptic potential (EPSP)
amplitudes and membrane potential in the muscle are measured with the bath
application of ATPA to compare if they are affected.

7

Figure 1- 4. Schematic model of predicted t-ACPD action at Drosophila NMJ.
trans-(±)-1-Amino-1,3-cyclopentanedicarboxylic acid monohydrate (t-ACPD) is a
well-known metabotropic glutamate receptor agonist. If t-ACPD has an action
either presynaptically or postsynaptically it would alter the amplitude of evoked
response. Excitatory postsynaptic potential (EPSP) amplitudes and membrane
potential in the evoked response are measured with the bath application of tACPD to see if there is a t-ACPD action through the metabotropic glutamate
receptors. In the figure, narrow arrow is described to show the action of t-ACPD
on the postsynaptic receptor because of a small possibility of a postsynaptic
action on receptors at the Drosophila NMJ. The receptors are known as
ionotropic glutamate receptors.
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GluR‐IIA
GluR‐IIB
GluR‐IIC
GluR‐IID
GluR‐IIE
GluR‐5

------------------MRLCPVVIYAFIIIIGFLEGIIALGGDDRNEITVG----AIFYENEKEIELSFDQAFREVN--NMKFSELRFVTIKRYMPTNDSFLLQQ
-------------------------MHGLQFLVLLALAIASGANEDTLVITVG----AIFYENEKEIELSFDQAFREVN--NMKFSELRFVTIKRYMPTNDSFLLQQ
MKKELSGNSSARWPQMFGGNSREAGMWQRILLLGCMWSAFFMCRSRGQQINIG----AFFYDDELELEKEFMTVVNAINGPESEQTMRFYPLIKRLKPEDGSVTMQE
-------------MHFCWIS---LIILSLSRVQAQFYGGNAYEASSGQSIRLG----LITDDATDRIRQTFEHAISVVN----NELGVPLVGETEQVAYGNSVQAFA
----------MFFNHFVILWSLFSIHISVNWAQYENFGG-YDNYQSLESVPIG----LLTDQNTEQMNIVFDHAIDVAN----QEVGTSLTSLKEEVNYGDAYQSYG
------------MEHGTLLAQPGLWTRDTSWALLYFLCYILPQTAP-QVLRIGGIFETVENEPVNVEELAFKFAVTSINRNRTLMPNTTLTYDIQRINLFDSFEASR

ITCELISNGVAAIFGPSSKAASDIVAQIANATGIPHIEYDLKLEATRQEQLNHQMSINVAPSLSVLSRAYFEIIKSN-YEWRTFTLIYETPEG--LARLQDLMNIQA
ITCELISNGVAAIFGPSSKAASDIVAQIANATGIPHIEYDLKLQQSNRERMNHQLTVNVAPMELFLSAAFSDILASKTFDWKSFTIAYERSSH--LIRLQHILAWKQ
HACDLIDNGVAAIFGPSSKAASDIVALVCNSTGIPHIEFDISDEGIQAEKPNHQMTLNLYPAQAILSKAYADIVQNF--GWRKFTIVYDADDARAAARLQDLLQLRE
QLCRLMQSGVGAVFGPAARHTASHLLNACDSKDIPFIYPHLSWGSNPDG-------FNLHPSPEDIANALYDIVNQF--EWSRFIFCYESAEY--LKILDHLMTRYG
KLCRMLETGIAGVFGPSSRHTAVHLMSICDAMDIPHIYSYMS--ENAEG-------FNLHPHPADLAKALYSLITEF--NWTRFIFLYESAEY--LNILNELTTMLG
RACDQLALGVAALFGPSHSSSVSAVQSICNALEVPHIQTRWKHPSVDNKDL---FYINLYPDYAAISRAILDLVLYY--NWKTVTVVYEDSTG--LIRLQELIKAPS

9

LNSDYVKLRNLADYADDYRILWKETDETFHEQRIILDCEPKTLKELLKVSIDFKLQGPFRNWFLTHLDTHNSGLRDIYN--EDFKANITSVRLKVVDANPFERKKTR
LHKAGIKMQEFE-RGDDYRILWKRINN-AREKFVLLDCPSDILVDVINASIGYNMTGSFNHLFLTNLDTHLSGIDGFYS--RDFTVAVAAVRIRTYVPPPVHDEIDV
VHNDVVRVRKFH-KDDDFRVMWKSIRG---ERRVVLDCEPNMLVELLNSSTEFGLTGQYNHIFLTNLETYTDHLEELAADNETFAVNITAARLLVNPDPPPYSLPYG
IKGPVIKVMRYDLNLNGNYKSVLRRIRKSEDSRIVVVGSTTGVAELLRQAQQVGIMNEDYTYIIGNLNLHTFDLEEYKYS----EANITGIRMFSPDQEEVRDLMEK
KSGTVITVLRYDMQLNGNYKQVLRRVRKSVDNRIVVVGSSETMPEFLNQAQQVGIINEDYKYIIGNLDFHSFDLEEYKYS----EANITGLRLFSPEKMAVKELLMK
RYNIKIKIRQLPSGNK-DAKPLLKEMKKGKEFYVIFDCSHETAAEILKQILFMGMMTEYYHYFFTTLDLFALDLELYRYS----GVNMTGFRLLNIDNPHVSSIIEK

LT-KVDQILGN---------QTMLPILIYDAVVLFASSARNVIAAMQP-FHPP----NRHCGSSSPWMLGAFIVNEMKTISEDDVEPHFKTENMKLDEYGQRIHFNL
FDNSVDTRFS-----------SLGSQLVYDSIVLFYN-ALLEISQRPG-FYIP----NFSCG-RGFWQPGPRLVEQMKQITPKMVKPPFKTQRLQINADGQREDFNL
YVTQRDNIVYES----SDPPRTLIHDLIHDALQLFAQSWRNASFFYPDRMVVPRITCDFAASGGRTWAMGRYLARLMKGTSG-VNNTNFRTSILQFDEDGQRITFNI
LHQELGESEP---VNSGSTFITMEMALTYDAVRVIAETTKHLPYQPQM--------LNCSERHDNVQPDGSTFRNYMR--SLEIKEKTITGRIYFEGNVRKGFTFDV
LGYPTDQDE----FRNGSCPITVEMALTYDAVQLFAQTLKNLPFKPMP--------QNCSQRTESVRDDGSSFKNYMR--TLRLTDRLLTGPIYFEGNVRKGYHLDV
WSMERLQAPPRPETGLLDGMMTTEAALMYDAVYMVAIASHRASQLTVS--------SLQCHRHKPWR-LGPRFMNLIK--EARWDGLTGHITFNKTNGLRKDFDLDI

Figure 1-5a. Sequence alignment with predicted amino acid sequences of the postsynaptic receptor subunits at
Drosophila NMJ and human’s kainate receptor subunits. Compared subunits are shown on the left of the first row in
aligned sequences. Identical and similar amino acids matched are colored by red and putative extracellular domains are
shaded by yellow, respectively. ClustalW2 is used for sequence analysis.

(Figure 1-5a cont.)
EIYKPTVNEPMMVWTPDN---GIKKRLLN----LELESAGTTQDFSEQRKVYTVVTHYEEPYFMMKEDHE--NFRGREKYEGYAVDLISKLSELMEFDYEFMIVNGN
EVYNPIIDRVTHIWNKEFQLVDFEKLRENSTQALKQKRLQNKEDFSQKPIRYTVATRVGKPYFSWREEPEGVHYEGNERFEGYAVDLIYMLAQECKFDFNFEPVRDN
EVYDPLDGIGIAIWDPRG-----------------QITQLNVDVKAQKKMIYRVATRIGPPYFSYNETARELNLTGNALYQGYAVDLIDAIARHVGFEYVFVPVADQ
IELQTSGLVKVGTWEEGK------DFEFQR-PPQAVNFNDIDDGSLVNKTFIVLISVATKPYASLVESID--TLIGNNQFQGYGVDLIKELADKLGFNFTFRDGGND
IELQPSGIVKVGTWDEDR------QYRPQRLAPTTAQFDSVDN-SLANKTFIILLSVPNKPYAQLVETYK--QLEGNSQYEGYGVDLIKELADKLGFNFTFVNGGND
ISLKEEGTEKIGIWNSNS------GLNMTD---SNKDKSSNITDSLANRTLIVTT-ILEEPYVMYRKSDK--PLYGNDRFEGYCLDLLKELSNILGFIYDVKLVPDG
TM1
--GKYNPETKQWDGIIRKLIDHHAQIGVCDLTITQMRRSVVDFTVPFMQLGISILHYKSPPEPKNQFAFLEPFAVEVWIYMIFAQLIMTLAFVFIARLSYREWLPPN
KYGSYDANTDEWDGIIRQLIDNNAQIGICDLTITQARRSVVDFTVPFMQLGISILSYKEPPPKADIYAFLNPYNAEVWLFVMIAMMITAFALIFTGRIDQYEWDQPV
QYGKLDKETKQWNGIIGEIINNDAHMGICDLTITQARKTAVDFTVPFMQLGVSILAYKSPHVEKTLDAYLAPFGGEVWIWILISVFVMTFLKTIVARISKMDWENPH
-YGSFNKTTNSTSGMLKEIVEGRADLAITDLTITSEREEVIDFSIPFMNLGIAILYVKPQKAPPALFSFMDPFSSEVWLYLGIAYLGVSLCFFIIGRLSPIEWDNPY
-YGSYNKSTNESTGMLREIMTGRADLAITDLTITSEREQALDFTIPFMNLGIAILYLKPQKATPELFTFMDPFSEEVWWFLGFSFLGVSLSFFILGRLSPSEWDNPY
-KYGAQNDKGEWNGMVKELIDHRADLAVAPLTITYVREKVIDFSKPFMTLGISILYRKPNGTNPGVFSFLNPLSPDIWMYVLLACLGVSCVLFVIARFTPYEWYNPH
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TM2
TM3
PAIQDPDELENIWNVNNSTWLMVGSIMQQGCDILPRGPHMRILTGMWWFFALMMLSTYTANLAAFLTSNKWQSSIKSLQDLIEQD-KVHFGSMRGGSTSLFFSESND
ENVNREMERQNIWHLSNALWLVLGSMLNQGCDLLPRGLPMRLLTAFWWIFALLISQTYIAKLAAFITSSKIAGDIGSLHDLVDQN-KVQFGTIRGGATSVYFSESND
PCNRDPEVLENQWRIHNTGWLTVASIMTAGCDILPRSPQVRMFEATWWIFAIIIANSYTANLAAFLTSSKMEGSIANLKDLSAQK-KVKFGTIYGGSTYNLLADSNE
PCIEEPEELENQFTINNSLWFTTGALLQQGSEIAPKALSTRTISAIWWFFTLIMVSSYTANLAAFLTIENPTSPINSVKDLADNKDDVQYGAKRTGSTRNFFSTSEE
PCIEEPEELENQFTLGNSIWFTTGALLQQGSEIGPKALSTRTVASFWWFFTLIVVSSYTANLAAFLTIEKPQSLINSVDDLADNKDGVVYGAKKTGSTRNFFMTSAE
PCNPDSDVVENNFTLLNSFWFGVGALMQQGSELMPKALSTRIVGGIWWFFTLIIISSYTANLAAFLTVERMESPIDSADDLAKQT-KIEYGAVRDGSTMTFFKKSKI

TDYQRAWNQMKDFNPSAFTSTNKEGVARVRKEKGGYAFLMETTSLTYNIERNCDLTQIGEQIGEKHYGLAVPLGSDYRTNLSVSILQLSERGELQKMKNKWWKNHNV
TDNRMAWNKMLSFKPDAFTKNNEEGVDRVKLSKGTYAFLMETTNLQYYVQRNCELTQIGESFGEKHYGIAVPLNADFRSNLSVGILRLSERGELFKLRNKWFNSNES
TVYRLAFNLMNNDDPSAYTKDNLEGVDRVRKNRGDYMFLMETTTLEYHREQNCDLRSVGEKFGEKHYAIAVPFGAEYRSNLSVAILKLSERGELYDLKQKWWKNPNA
PIYIKMNEYLNA-HPEMLMENNQQGVDKVKSG-TKYAFLMESTSIEFNTVRECNLTKVGDPLDEKGYGIAMVKNWPYRDKFNKALLELQEQGVLARLKNKWWNEVGA
ERYKKMNKFMSE-NPQYLTEDNMEGVNRVKTN-THYAFLMESTSIEYNTKRECNLKKIGDALDEKGYGIAMRKDWPHRGKFNNALLELQEQGVLEKMKNKWWNEVGT
STYEKMWAFMSSRQQTALVRNSDEGIQRVLT--TDYALLMESTSIEYVTQRNCNLTQIGGLIDSKGYGVGTPIGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNG-

(Figure 1-5a cont.)
TM4
-TCDS-YHEVDGDELSIIELGGVFLVLAGGVLIGVILGIFEFLWNVQNVAVEERVTPWQAFKAELIFALKFWVRKKPMRISS--SSDKSSSRRSS-----GSRRSSK
-TCDSNVPTIDDGQFDMDSVGGLFVVLIVGVVVGLVIGVAEFLWHVQRISVKEKIPPMLALKAEFYFVIRFWLTRKPLHTYR--QSRDSTSTGYSSLEQITSASSAK
-SCFEEPDPDATPDMTFEELRGIFYTLYAGILIAFLIGITEFLVYVQQVALEERLTFKDAFKKEIRFVLCVWNNRKPIVAGTPISSVRTTPRRSLDKSLDRTPKSSR
GVCSAKSDDDGPSELGVDNLSGIYVVLVIGSIISIIISILCWCYFVYKKAKNYEVPFCDALAEEFRIVIRFSENERPLKSAQSIYSRSRNSSQSIESLKTDSEENMP
GICATKEDAPDATPLDMNNLEGVFFVLLVGSCCALLYGIISWVLFVMKKAHHYRVPLRDALKEEFQFVIDFNNYVRVLKNSASIYSRSRQSSMSVASVAQESQ------CPEEDNKEASALGVENIGGIFIVLAAGLVLSVFVAIGEFIYKSRKNNDIEQCLSFNAIMEELGISLKNQKKIK--KKSRTKGKSSFTSILTCHQRRTQRKETVA

EKSRSKTVS--------------------------KKKKTRRIEK-------------------------RVVIGRSSEEMREMAQGSGSSSGSNNAGRGEKEARV
VED-------------------------------------------------------------------------------------------------------
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GluR‐IIE
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MKKELSGNSSARWPQMFGGNSREAGMWQRILLLGCMWSAFFMCRSRGQQINIG----AFFYDDELELEKEFMTVVNAINGPESEQTMRFYPLIKRLKPEDGSVTMQE
-------------MHFCWIS---LIILSLSRVQAQFYGGNAYEASSGQSIRLG----LITDDATDRIRQTFEHAISVVN----NELGVPLVGETEQVAYGNSVQAFA
----------MFFNHFVILWSLFSIHISVNWAQYENFGG-YDNYQSLESVPIG----LLTDQNTEQMNIVFDHAIDVAN----QEVGTSLTSLKEEVNYGDAYQSYG
------------MKIIFPILSNPVFRRTVKLLLCLLWIG--YSQGTTHVLRFGGIFEYVESGPMGAEELAFRFAVNTINRNRTLLPNTTLTYDTQKINLYDSFEASK

ITCELISNGVAAIFGPSSKAASDIVAQIANATGIPHIEYDLKLEATRQEQLNHQMSINVAPSLSVLSRAYFEIIKSN-YEWRTFTLIYETPEG--LARLQDLMNIQA
ISCDLIGSGVAAIFGPSSKTNSDIVEVLCNMTGIPHLQFDWHPQQSNRERMNHQLTVNVAPMELFLSAAFSDILASKTFDWKSFTIAYERSSH--LIRLQHILAWKQ
HACDLIDNGVAAIFGPSSKAASDIVALVCNSTGIPHIEFDISDEGIQAEKPNHQMTLNLYPAQAILSKAYADIVQNF--GWRKFTIVYDADDARAAARLQDLLQLRE
QLCRLMQSGVGAVFGPAARHTASHLLNACDSKDIPFIYP-------HLSWGSNPDGFNLHPSPEDIANALYDIVNQF--EWSRFIFCYESAEY--LKILDHLMTRYG
KLCRMLETGIAGVFGPSSRHTAVHLMSICDAMDIPHIYS-------YMS--ENAEGFNLHPHPADLAKALYSLITEF--NWTRFIFLYESAEY--LNILNELTTMLG
KACDQLSLGVAAIFGPSHSSSANAVQSICNALGVPHIQTRWK---HQVSDNKDSFYVSLYPDFSSLSRAILDLVQFF--KWKTVTVVYDDSTG--LIRLQELIKAPS
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VHNDVVRVRKFH-KDDDFRVMWKSIRG---ERRVVLDCEPNMLVELLNSSTEFGLTGQYNHIFLTNLETYTDHLEELAADNETFAVNITAARLLVNPDPPPYSLPYG
IKGPVIKVMRYDLNLNGNYKSVLRRIRKSEDSRIVVVGSTTGVAELLRQAQQVGIMNEDYTYIIGNLNLHTFDLEEYKYS----EANITGIRMFSPDQEEVRDLMEK
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LT-KVDQILGN-----QTMLPILIYDAVVLFASSARNVIAAMQP-FHPP----NRHCGSSSPWMLGAFIVNEMKTISEDDVEPHFKTENMKLDEYGQRIHFNLEIYK
FDNSVDTRFS-------SLGSQLVYDSIVLFYN-ALLEISQRPG-FYIP----NFSCG-RGFWQPGPRLVEQMKQITPKMVKPPFKTQRLQINADGQREDFNLEVYN
YVTQRDNIVYESSDPPRTLIHDLIHDALQLFAQSWRNASFFYPDRMVVPRITCDFAASGGRTWAMGRYLARLMKGTSG-VNNTNFRTSILQFDEDGQRITFNIEVYD
LHQELGESEP------VNSGSTFITMEMALTYDAVRVIAETTKHLPYQP-----QMLNCSERHDNVQPDGSTFRNYMRSLEIKEKTITGRIYFEGNVRKGFTFDVIE
LGYPTDQDE-------FRNGSCPITVEMALTYDAVQLFAQTLKNLPFKP-----MPQNCSQRTESVRDDGSSFKNYMRTLRLTDRLLTGPIYFEGNVRKGYHLDVIE
WSMERLQAPPK---PDSGLLDGFMTTDAALMYDAVHVVSVAVQQFPQMT-----VSSLQCNRHKPWR-FGTRFMSLIKEAHWEGLTGRITFNKTNGLRTDFDLDVIS

PTVNEPMMVWTPDN---GIKKRLLN----LELESAGTTQDFSEQRKVYTVVTHYEEPYFMMKEDHE--NFRGREKYEGYAVDLISKLSELMEFDYEFMIVNGN--GK
PIIDRVTHIWNKEFQLVDFEKLRENSTQALKQKRLQNKEDFSQKPIRYTVATRVGKPYFSWREEPEGVHYEGNERFEGYAVDLIYMLAQECKFDFNFEPVRDNKYGS
PLDGIGIAIWDPRG-----------------QITQLNVDVKAQKKMIYRVATRIGPPYFSYNETARELNLTGNALYQGYAVDLIDAIARHVGFEYVFVPVADQQYGK
LQTSGLVKVGTWEE----GKDFEFQR-PPQAVNFNDIDDGSLVNKTFIVLISVATKPYASLVESID--TLIGNNQFQGYGVDLIKELADKLGFNFTFRDGGN-DYGS
LQPSGIVKVGTWDE----DRQYRPQRLAPTTAQFDSVDN-SLANKTFIILLSVPNKPYAQLVETYK--QLEGNSQYEGYGVDLIKELADKLGFNFTFVNGGN-DYGS
LKEEGLEKIGTWDP----ASGLNMTE----SQKGKPANITDSLSNRSLIVTTILEEPYVLFKKSDK--PLYGNDRFEGYCIDLLRELSTILGFTYEIRLVEDGKYGA

(Figure 1-5a cont.)
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YDANTDEWDGIIRQLIDNNAQIGICDLTITQARRSVVDFTVPFMQLGISILSYKEPPPKADIYAFLNPYNAEVWLFVMIAMMITAFALIFTGRIDQYEWDQPVENVN
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FNKTTNSTSGMLKEIVEGRADLAITDLTITSEREEVIDFSIPFMNLGIAILYVKPQKAPPALFSFMDPFSSEVWLYLGIAYLGVSLCFFIIGRLSPIEWDNPYPCIE
YNKSTNESTGMLREIMTGRADLAITDLTITSEREQALDFTIPFMNLGIAILYLKPQKATPELFTFMDPFSEEVWWFLGFSFLGVSLSFFILGRLSPSEWDNPYPCIE
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TM3
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EPEELENQFTLGNSIWFTTGALLQQGSEIGPKALSTRTVASFWWFFTLIVVSSYTANLAAFLTIEKPQSLINSVDDLADNKDGVVYGAKKTGSTRNFFMTSAEERYK
DSDVVENNFTLLNSFWFGVGALMQQGSELMPKALSTRIVGGIWWFFTLIIISSYTANLAAFLTVERMESPIDSADDLAKQT-KIEYGAVEDGATMTFFKKSKISTYD
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RAWNQMKDFNPSAFTSTNKEGVARVRKEKGGYAFLMETTSLTYNIERNCDLTQIGEQIGEKHYGLAVPLGSDYRTNLSVSILQLSERGELQKMKNKWWKNHNV-TCD
MAWNKMLSFKPDAFTKNNEEGVDRVKLSKGTYAFLMETTNLQYYVQRNCELTQIGESFGEKHYGIAVPLNADFRSNLSVGILRLSERGELFKLRNKWFNSNES-TCD
LAFNLMNNDDPSAYTKDNLEGVDRVRKNRGDYMFLMETTTLEYHREQNCDLRSVGEKFGEKHYAIAVPFGAEYRSNLSVAILKLSERGELYDLKQKWWKNPNA-SCF
KMNEYLNAHPE-MLMENNQQGVDKVKSG-TKYAFLMESTSIEFNTVRECNLTKVGDPLDEKGYGIAMVKNWPYRDKFNKALLELQEQGVLARLKNKWWNEVGAGVCS
KMNKFMSENPQ-YLTEDNMEGVNRVKTN-THYAFLMESTSIEYNTKRECNLKKIGDALDEKGYGIAMRKDWPHRGKFNNALLELQEQGVLEKMKNKWWNEVGTGICA
KMWAFMSSRRQSVLVKSNEEGIQRVLT--SDYAFLMESTTIEFVTQRNCNLTQIGGLIDSKGYGVGTPMGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNG----C
TM4
S-YHEVDGDELSIIELGGVFLVLAGGVLIGVILGIFEFLWNVQNVAVEERVTPWQAFKAELIFALKFWVRKKPMRISS--SSDKSSSRRSS-----GSRRSSKEKSR
SNVPTIDDGQFDMDSVGGLFVVLIVGVVVGLVIGVAEFLWHVQRISVKEKIPPMLALKAEFYFVIRFWLTRKPLHTYR--QSRDSTSTGYSSLEQITSASSAKKKKK
EEPDPDATPDMTFEELRGIFYTLYAGILIAFLIGITEFLVYVQQVALEERLTFKDAFKKEIRFVLCVWNNRKPIVAGTPISSVRTTPRRSLDKSLDRTPKSSRRVVI
AKSDDDGPSELGVDNLSGIYVVLVIGSIISIIISILCWCYFVYKKAKNYEVPFCDALAEEFRIVIRFSENERPLKSAQSIYSRSRNSSQSIESLKTDSEENMPVEDTKEDAPDATPLDMNNLEGVFFVLLVGSCCALLYGIISWVLFVMKKAHHYRVPLRDALKEEFQFVIDFNNYVRVLKNSASIYSRSRQSSMSVASVAQESQ-------PEEESKEASALGVQNIGGIFIVLAAGLVLSVFVAVGEFLYKSKKNAQ--------------------------LEKESSIWLVPPYHPDTV----------------

(Figure 1-5a cont.)
SKTVS--------------------------TRRIEK-------------------------GRSSEEMREMAQGSGSSSGSNNAGRGEKEARV
----------------------------------------------------------------------------------------------
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(Figure 1-5a cont.)
GluR‐IIA
GluR‐IIB
GluR‐IIC
GluR‐IID
GluR‐IIE
GluR‐6

------------------MRLCPVVIYAFIIIIGFLEGIIALGGDDRNEITVG----AIFYENEKEIELSFDQAFREVN--NMKFSELRFVTIKRYMPTNDSFLLQQ
-------------------------MHGLQFLVLLALAIASGANEDTLVIKIG----AIFFDTEMKLADAFSAALEEVN--AIN-PALKLDAIKRYVTVDDSIVLQD
MKKELSGNSSARWPQMFGGNSREAGMWQRILLLGCMWSAFFMCRSRGQQINIG----AFFYDDELELEKEFMTVVNAINGPESEQTMRFYPLIKRLKPEDGSVTMQE
-------------MHFCWIS---LIILSLSRVQAQFYGGNAYEASSGQSIRLG----LITDDATDRIRQTFEHAISVVN----NELGVPLVGETEQVAYGNSVQAFA
----------MFFNHFVILWSLFSIHISVNWAQYENFGG-YDNYQSLESVPIG----LLTDQNTEQMNIVFDHAIDVAN----QEVGTSLTSLKEEVNYGDAYQSYG
------------MKIIFPILSNPVFRRTVKLLLCLLWIG--YSQGTTHVLRFGGIFEYVESGPMGAEELAFRFAVNTINRNRTLLPNTTLTYDTQKINLYDSFEASK

ITCELISNGVAAIFGPSSKAASDIVAQIANATGIPHIEYDLKLEATRQEQLNHQMSINVAPSLSVLSRAYFEIIKSN-YEWRTFTLIYETPEG--LARLQDLMNIQA
ISCDLIGSGVAAIFGPSSKTNSDIVEVLCNMTGIPHLQFDWHPQQSNRERMNHQLTVNVAPMELFLSAAFSDILASKTFDWKSFTIAYERSSH--LIRLQHILAWKQ
HACDLIDNGVAAIFGPSSKAASDIVALVCNSTGIPHIEFDISDEGIQAEKPNHQMTLNLYPAQAILSKAYADIVQNF--GWRKFTIVYDADDARAAARLQDLLQLRE
QLCRLMQSGVGAVFGPAARHTASHLLNACDSKDIPFIYP-------HLSWGSNPDGFNLHPSPEDIANALYDIVNQF--EWSRFIFCYESAEY--LKILDHLMTRYG
KLCRMLETGIAGVFGPSSRHTAVHLMSICDAMDIPHIYS-------YMS--ENAEGFNLHPHPADLAKALYSLITEF--NWTRFIFLYESAEY--LNILNELTTMLG
KACDQLSLGVAAIFGPSHSSSANAVQSICNALGVPHIQTRWK---HQVSDNKDSFYVSLYPDFSSLSRAILDLVQFF--KWKTVTVVYDDSTG--LIRLQELIKAPS
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LKEEGLEKIGTWDP----ASGLNMTE----SQKGKPANITDSLSNRSLIVTTILEEPYVLFKKSDK--PLYGNDRFEGYCIDLLRELSTILGFTYEIRLVEDGKYGA

(Figure 1-5a cont.)
TM1
YNPETKQWDGIIRKLIDHHAQIGVCDLTITQMRRSVVDFTVPFMQLGISILHYKSPPEPKNQFAFLEPFAVEVWIYMIFAQLIMTLAFVFIARLSYREWLPPNPAIQ
YDANTDEWDGIIRQLIDNNAQIGICDLTITQARRSVVDFTVPFMQLGISILSYKEPPPKADIYAFLNPYNAEVWLFVMIAMMITAFALIFTGRIDQYEWDQPVENVN
LDKETKQWNGIIGEIINNDAHMGICDLTITQARKTAVDFTVPFMQLGVSILAYKSPHVEKTLDAYLAPFGGEVWIWILISVFVMTFLKTIVARISKMDWENPHPCNR
FNKTTNSTSGMLKEIVEGRADLAITDLTITSEREEVIDFSIPFMNLGIAILYVKPQKAPPALFSFMDPFSSEVWLYLGIAYLGVSLCFFIIGRLSPIEWDNPYPCIE
YNKSTNESTGMLREIMTGRADLAITDLTITSEREQALDFTIPFMNLGIAILYLKPQKATPELFTFMDPFSEEVWWFLGFSFLGVSLSFFILGRLSPSEWDNPYPCIE
QDDANGQWNGMVRELIDHKADLAVAPLAITYVREKVIDFSKPFMTLGISILYRKPNGTNPGVFSFLNPLSPDIWMYILLAYLGVSCVLFVIARFSPYEWYNPHPCNP
TM2
TM3
DPDELENIWNVNNSTWLMVGSIMQQGCDILPRGPHMRILTGMWWFFALMMLSTYTANLAAFLTSNKWQSSIKSLQDLIEQD-KVHFGSMRGGSTSLFFSESNDTDYQ
REMERQNIWHLSNALWLVLGSMLNQGCDLLPRGLPMRLLTAFWWIFALLISQTYIAKLAAFITSSKIAGDIGSLHDLVDQN-KVQFGTIRGGATSVYFSESNDTDNR
DPEVLENQWRIHNTGWLTVASIMTAGCDILPRSPQVRMFEATWWIFAIIIANSYTANLAAFLTSSKMEGSIANLKDLSAQK-KVKFGTIYGGSTYNLLADSNETVYR
EPEELENQFTINNSLWFTTGALLQQGSEIAPKALSTRTISAIWWFFTLIMVSSYTANLAAFLTIENPTSPINSVKDLADNKDDVQYGAKRTGSTRNFFSTSEEPIYI
EPEELENQFTLGNSIWFTTGALLQQGSEIGPKALSTRTVASFWWFFTLIVVSSYTANLAAFLTIEKPQSLINSVDDLADNKDGVVYGAKKTGSTRNFFMTSAEERYK
DSDVVENNFTLLNSFWFGVGALMQQGSELMPKALSTRIVGGIWWFFTLIIISSYTANLAAFLTVERMESPIDSADDLAKQT-KIEYGAVEDGATMTFFKKSKISTYD

16

RAWNQMKDFNPSAFTSTNKEGVARVRKEKGGYAFLMETTSLTYNIERNCDLTQIGEQIGEKHYGLAVPLGSDYRTNLSVSILQLSERGELQKMKNKWWKNHNV-TCD
MAWNKMLSFKPDAFTKNNEEGVDRVKLSKGTYAFLMETTNLQYYVQRNCELTQIGESFGEKHYGIAVPLNADFRSNLSVGILRLSERGELFKLRNKWFNSNES-TCD
LAFNLMNNDDPSAYTKDNLEGVDRVRKNRGDYMFLMETTTLEYHREQNCDLRSVGEKFGEKHYAIAVPFGAEYRSNLSVAILKLSERGELYDLKQKWWKNPNA-SCF
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TM4
S-YHEVDGDELSIIELGGVFLVLAGGVLIGVILGIFEFLWNVQNVAVEERVTPWQAFKAELIFALKFWVRKKPMRISS--SSDKSSSRRSS-----GSRRSSKEKSR
SNVPTIDDGQFDMDSVGGLFVVLIVGVVVGLVIGVAEFLWHVQRISVKEKIPPMLALKAEFYFVIRFWLTRKPLHTYR--QSRDSTSTGYSSLEQITSASSAKKKKK
EEPDPDATPDMTFEELRGIFYTLYAGILIAFLIGITEFLVYVQQVALEERLTFKDAFKKEIRFVLCVWNNRKPIVAGTPISSVRTTPRRSLDKSLDRTPKSSRRVVI
AKSDDDGPSELGVDNLSGIYVVLVIGSIISIIISILCWCYFVYKKAKNYEVPFCDALAEEFRIVIRFSENERPLKSAQSIYSRSRNSSQSIESLKTDSEENMPVEDTKEDAPDATPLDMNNLEGVFFVLLVGSCCALLYGIISWVLFVMKKAHHYRVPLRDALKEEFQFVIDFNNYVRVLKNSASIYSRSRQSSMSVASVAQESQ-------PEEESKEASALGVQNIGGIFIVLAAGLVLSVFVAVGEFLYKSKKNAQ--------------------------LEKESSIWLVPPYHPDTV----------------

(Figure 1-5a cont.)
SKTVS--------------------------TRRIEK-------------------------GRSSEEMREMAQGSGSSSGSNNAGRGEKEARV
----------------------------------------------------------------------------------------------
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(Figure 1-5a cont.)
GluR‐IIA
GluR‐IIB
GluR‐IIC
GluR‐IID
GluR‐IIE
KA1

------------------MRLCPVVIYAFIIIIGFLEGIIALGGDDRNEITVGAIFYE---NEKEIELSFDQAFREVN--NMKFSELRFVTIKRYMPTNDSFLLQQI
-------------------------MHGLQFLVLLALAIASGANEDTLVIKIGAIFFD---TEMKLADAFSAALEEVN--AIN-PALKLDAIKRYVTVDDSIVLQDI
MKKELSGNSSARWPQMFGGNSREAGMWQRILLLGCMWSAFFMCRSRGQQINIGAFFYD---DELELEKEFMTVVNAINGPESEQTMRFYPLIKRLKPEDGSVTMQEH
-------------MHFCWIS---LIILSLSRVQAQFYGGNAYEASSGQSIRLGLITDD---ATDRIRQTFEHAISVVN----NELGVPLVGETEQVAYGNSVQAFAQ
----------MFFNHFVILWSLFSIHISVNWAQYENFGG-YDNYQSLESVPIGLLTDQ---NTEQMNIVFDHAIDVAN----QEVGTSLTSLKEEVNYGDAYQSYGK
-------------------------MPRVSAPLVLLPAWLVMVACSPHSLRIAAILDDPMECSRGERLSITLAKNRINRAPERLGKAKVEVDIFELLRDSEYETAET

TCELISNGVAAIFGPSSK-AASDIVAQIANATGIPHIEYDLKLEATRQEQLNHQMSINVAPSLSVLSRAYFEIIKSN-YEWRTFTLIYETPEG--LARLQDLMNIQA
SCDLIGSGVAAIFGPSSK-TNSDIVEVLCNMTGIPHLQFDWHPQQSNRERMNHQLTVNVAPMELFLSAAFSDILASKTFDWKSFTIAYERSSH--LIRLQHILAWKQ
ACDLIDNGVAAIFGPSSK-AASDIVALVCNSTGIPHIEFDISDEGIQAEKPNHQMTLNLYPAQAILSKAYADIVQNF--GWRKFTIVYDADDARAAARLQDLLQLRE
LCRLMQSGVGAVFGPAAR-HTASHLLNACDSKDIPFIYPHLSWGSNPDG-------FNLHPSPEDIANALYDIVNQF--EWSRFIFCYESAEY--LKILDHLMTRYG
LCRMLETGIAGVFGPSSR-HTAVHLMSICDAMDIPHIYSYMS--ENAEG-------FNLHPHPADLAKALYSLITEF--NWTRFIFLYESAEY--LNILNELTTMLG
MCQILPKGVVAVLGPSSSPASSSIISNICGEKEVPHFKVAPEEFVKFQFQR--FTTLNLHPSNTDISVAVAGILNFF--NCTTACLICAKAEC--LLNLEKLLRQFL
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LNSDYVKLRNLAD-YADDYRILWKETDETFHEQRIILDCEPKTLKELLKVSIDFKLQGPFRNWFLTHLDTHNSGLRDIYN--EDFKANITSVRLKVVDANPFERKKT
LHKAGIKMQEFE--RGDDYRILWKRINN-AREKFVLLDCPSDILVDVINASIGYNMTGSFNHLFLTNLDTHLSGIDGFYS--RDFTVAVAAVRIRTYVPPPVHDEID
VHNDVVRVRKFH--KDDDFRVMWKSIRG---ERRVVLDCEPNMLVELLNSSTEFGLTGQYNHIFLTNLETYTDHLEELAADNETFAVNITAARLLVNPDPPPYSLPY
IKGPVIKVMRYDLNLNGNYKSVLRRIRK-SEDSRIVVVGSTTGVAELLRQAQQVGIMNEDYTYIIGNLNLHTFDLEEYKYS----EANITGIRMFSPDQEEVRDLME
KSGTVITVLRYDMQLNGNYKQVLRRVRK-SVDNRIVVVGSSETMPEFLNQAQQVGIINEDYKYIIGNLDFHSFDLEEYKYS----EANITGLRLFSPEKMAVKELLM
ISKDTLSVRMLDD--TRDPTPLLKEIRD-DKTATIIIHANASMSHTILLKAAELGMVSAYYTYIFTNLEFSLQRMDSLVDD----RVNILGFSIFNQSHAFFQEFAQ

RLT-KVDQILGN------QTMLPILIYDAVVLFASSARNVIAAMQP-FHPP----NRHCGSSSPWMLGAFIVNEMKTISEDDVEPHFKTENMKLDEYGQRIHFNLEI
VFDNSVDTRFS--------SLGSQLVYDSIVLFYN-ALLEISQRPG-FYIP----NFSCG-RGFWQPGPRLVEQMKQITPKMVKPPFKTQRLQINADGQREDFNLEV
GYVTQRDNIVYESSD-PPRTLIHDLIHDALQLFAQSWRNASFFYPDRMVVPRITCDFAASGGRTWAMGRYLARLMKGTSG-VNNTNFRTSILQFDEDGQRITFNIEV
KLHQELGESEPVNSGSTFITMEMALTYDAVRVIAETTKHLPYQPQM--------LNCSERHDNVQPDGSTFRNYMR--SLEIKEKTITGRIYFEGNVRKGFTFDVIE
KLGYPTDQDE-FRNGSCPITVEMALTYDAVQLFAQTLKNLPFKPMP--------QNCSQRTESVRDDGSSFKNYMR--TLRLTDRLLTGPIYFEGNVRKGYHLDVIE
SLNQSWQENCDHVPFTG-PALSSALLFDAVYAVVTAVQELNRSQEIG------VKPLSCGSAQIWQHGTSLMNYLR---MVELEGLTGHIEFNSKGQRSNYALKILQ

YKPTVNEPMMVWTPDN---GIKKRLLN----LELESAGTTQDFSEQRKVYTVVTHYE-EPYFMMKEDHE--NFRGREKYEGYAVDLISKLSELMEFDYEFMIVNGNYNPIIDRVTHIWNKEFQLVDFEKLRENSTQALKQKRLQNKEDFSQKPIRYTVATRVG-KPYFSWREEPEGVHYEGNERFEGYAVDLIYMLAQECKFDFNFEPVRDNK
YDPLDGIGIAIWDPRG-----------------QITQLNVDVKAQKKMIYRVATRIG-PPYFSYNETARELNLTGNALYQGYAVDLIDAIARHVGFEYVFVPVADQQ
LQTSGLVKVGTWEEGK-------DFEFQR-PPQAVNFNDIDDGSLVNKTFIVLISVATKPYASLVESID--TLIGNNQFQGYGVDLIKELADKLGFNFTFR-DGGND
LQPSGIVKVGTWDEDR-------QYRPQRLAPTTAQFDSVDN-SLANKTFIILLSVPNKPYAQLVETYK--QLEGNSQYEGYGVDLIKELADKLGFNFTFV-NGGND
FTRNGFRQIGQWHVAEG-------------LSMDSHLYASNISDTLFNTTLVVTTILENPYLMLKGNHQ--EMEGNDRYEGFCVDMLKELAEILRFNYKIRLVGDGV

(Figure 1-5a cont.)
TM1
-GKYNPETKQWDGIIRKLIDHHAQIGVCDLTITQMRRSVVDFTVPFMQLGISILHYKSPPEPKNQFAFLEPFAVEVWIYMIFAQLIMTLAFVFIARLSYREWLPPNP
YGSYDANTDEWDGIIRQLIDNNAQIGICDLTITQARRSVVDFTVPFMQLGISILSYKEPPPKADIYAFLNPYNAEVWLFVMIAMMITAFALIFTGRIDQYEWDQPVE
YGKLDKETKQWNGIIGEIINNDAHMGICDLTITQARKTAVDFTVPFMQLGVSILAYKSPHVEKTLDAYLAPFGGEVWIWILISVFVMTFLKTIVARISKMDWENPHP
YGSFNKTTNSTSGMLKEIVEGRADLAITDLTITSEREEVIDFSIPFMNLGIAILYVKPQKAPPALFSFMDPFSSEVWLYLGIAYLGVSLCFFIIGRLSPIEWDNPYP
YGSYNKSTNESTGMLREIMTGRADLAITDLTITSEREQALDFTIPFMNLGIAILYLKPQKATPELFTFMDPFSEEVWWFLGFSFLGVSLSFFILGRLSPSEWDNPYP
YGVPEANG-TWTGMVGELIARKADLAVAGLTITAEREKVIDFSKPFMTLGISILYRVHMGRKPGYFSFLDPFSPGVWLFMLLAYLAVSCVLFLVARLTPYEWYSPHP
TM2
TM3
AIQ-DPDELENIWNVNNSTWLMVGSIMQQGCDILPRGPHMRILTGMWWFFALMMLSTYTANLAAFLTSNKWQSSIKSLQDLIE-QDKVHFGSMRGGSTSLFFSESND
NVN-REMERQNIWHLSNALWLVLGSMLNQGCDLLPRGLPMRLLTAFWWIFALLISQTYIAKLAAFITSSKIAGDIGSLHDLVD-QNKVQFGTIRGGATSVYFSESND
CNR-DPEVLENQWRIHNTGWLTVASIMTAGCDILPRSPQVRMFEATWWIFAIIIANSYTANLAAFLTSSKMEGSIANLKDLSA-QKKVKFGTIYGGSTYNLLADSNE
CIE-EPEELENQFTINNSLWFTTGALLQQGSEIAPKALSTRTISAIWWFFTLIMVSSYTANLAAFLTIENPTSPINSVKDLADNKDDVQYGAKRTGSTRNFFSTSEE
CIE-EPEELENQFTLGNSIWFTTGALLQQGSEIGPKALSTRTVASFWWFFTLIVVSSYTANLAAFLTIEKPQSLINSVDDLADNKDGVVYGAKKTGSTRNFFMTSAE
CAQGRCNLLVNQYSLGNSLWFPVGGFMQQGSTIAPRALSTRCVSGVWWAFTLIIISSYTANLAAFLTVQRMDVPIESVDDLAD-QTAIEYGTIHGGSSMTFFQNSRY
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TDYQRAWNQMKDFNPSAFTSTNKEGVARVRKEKGGYAFLMETTSLTYNIERNCDLTQIGEQIGEKHYGLAVPLGSDYRTNLSVSILQLSERGELQKMKNKWWKNHNV
TDNRMAWNKMLSFKPDAFTKNNEEGVDRVKLSKGTYAFLMETTNLQYYVQRNCELTQIGESFGEKHYGIAVPLNADFRSNLSVGILRLSERGELFKLRNKWFNSNES
TVYRLAFNLMNNDDPSAYTKDNLEGVDRVRKNRGDYMFLMETTTLEYHREQNCDLRSVGEKFGEKHYAIAVPFGAEYRSNLSVAILKLSERGELYDLKQKWWKNPNA
PIYIKMNEYLNA-HPEMLMENNQQGVDKVKSG-TKYAFLMESTSIEFNTVRECNLTKVGDPLDEKGYGIAMVKNWPYRDKFNKALLELQEQGVLARLKNKWWNEVGA
ERYKKMNKFMSE-NPQYLTEDNMEGVNRVKTN-THYAFLMESTSIEYNTKRECNLKKIGDALDEKGYGIAMRKDWPHRGKFNNALLELQEQGVLEKMKNKWWNEVGT
QTYQRMWNYMYSKQPSVFVKSTEEGIARVLNS--NYAFLLESTMNEYYRQRNCNLTQIGGLLDTKGYGIGMPVGSVFRDEFDLAILQLQENNRLEILKRKWWEGGKC
TM4
-TCDS-YHEVDGDELSIIELGGVFLVLAGGVLIGVILGIFEFLWNVQNVAVEERVTPWQAFKAELIFALKFWVRKKPMRISS--SSDKSSSRRSS-----GSRRSSK
-TCDSNVPTIDDGQFDMDSVGGLFVVLIVGVVVGLVIGVAEFLWHVQRISVKEKIPPMLALKAEFYFVIRFWLTRKPLHTYR--QSRDSTSTGYSSLEQITSASSAK
-SCFEEPDPDATPDMTFEELRGIFYTLYAGILIAFLIGITEFLVYVQQVALEERLTFKDAFKKEIRFVLCVWNNRKPIVAGTPISSVRTTPRRSLDKSLDRTPKSSR
GVCSAKSDDDGPSELGVDNLSGIYVVLVIGSIISIIISILCWCYFVYKKAKNYEVPFCDALAEEFRIVIRFSENERPLKSAQSIYSRSRNSSQSIESLKTDSEENMP
GICATKEDAPDATPLDMNNLEGVFFVLLVGSCCALLYGIISWVLFVMKKAHHYRVPLRDALKEEFQFVIDFNNYVRVLKNSASIYSRSRQSSMSVASVAQESQ-------PKEEDHRAKGLGMENIGGIFVVLICGLIVAIFMAMLEFLWTLR-HSEATEVSVCQEMVTELRSIILCQDSIHPRRRRAAVPPPRPPIPEERRPRGTATLSNGK

(Figure 1-5a cont.)
EKSRSKTVS-------------------------------------------------------KKKKTRRIEK------------------------------------------------------RVVIGRSSEEMREMAQGSGSSSGSNNAGRGEKEARV----------------------------VED-----------------------------------------------------------------------------------------------------------------------------LCGAGEPDQLAQRLAQEAALVARGCTHIRVCPECRRFQGLRARPSPARSEESLEWEKTTNSSEPE
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(Figure 1-5a cont.)
GluR‐IIA
GluR‐IIB
GluR‐IIC
GluR‐IID
GluR‐IIE
KA2

------------------MRLCPVVIYAFIIIIGFLEGIIALGGDDRNEITVGAIFYENEKE---IELSFDQAFREVN--NMKFSELRFVTIKRYMPTNDSFLLQQI
-------------------------MHGLQFLVLLALAIASGANEDTLVIKIGAIFFDTEMK---LADAFSAALEEVN--AIN-PALKLDAIKRYVTVDDSIVLQDI
MKKELSGNSSARWPQMFGGNSREAGMWQRILLLGCMWSAFFMCRSRGQQINIGAFFYDDELE---LEKEFMTVVNAINGPESEQTMRFYPLIKRLKPEDGSVTMQEH
-------------MHFCWIS---LIILSLSRVQAQFYGGNAYEASSGQSIRLGLITDDATDR---IRQTFEHAISVVN----NELGVPLVGETEQVAYGNSVQAFAQ
----------MFFNHFVILWSLFSIHISVNWAQYENFGG-YDNYQSLESVPIGLLTDQNTEQ---MNIVFDHAIDVAN----QEVGTSLTSLKEEVNYGDAYQSYGK
--------------------------MPAELLLLLIVAFASPSCQVLSSLRMAAILDDQTVCGRGERLALALAREQINGIIEVPAKARVEVDIFELQRDSQYETTDT

TCELISNGVAAIFGPSSK-AASDIVAQIANATGIPHIEYDLKLEATRQEQLNHQMSINVAPSLSVLSRAYFEIIKSN-YEWRTFTLIYETPEG--LARLQDLMNIQA
SCDLIGSGVAAIFGPSSK-TNSDIVEVLCNMTGIPHLQFDWHPQQSNRERMNHQLTVNVAPMELFLSAAFSDILASKTFDWKSFTIAYERSSH--LIRLQHILAWKQ
ACDLIDNGVAAIFGPSSK-AASDIVALVCNSTGIPHIEFDISDEGIQAEKPNHQMTLNLYPAQAILSKAYADIVQNF--GWRKFTIVYDADDARAAARLQDLLQLRE
LCRLMQSGVGAVFGPAAR-HTASHLLNACDSKDIPFIYPHLSWGSNPDG-------FNLHPSPEDIANALYDIVNQF--EWSRFIFCYESAEY--LKILDHLMTRYG
LCRMLETGIAGVFGPSSR-HTAVHLMSICDAMDIPHIYSYMS--ENAEG-------FNLHPHPADLAKALYSLITEF--NWTRFIFLYESAEY--LNILNELTTMLG
MCQILPKGVVSVLGPSSSPASASTVSHICGEKEIPHIKVGPE--ETPRLQYLRFASVSLYPSNEDVSLAVSRILKSF--NYPSASLICAKAEC--LLRLEELVRGFL
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LNSDYVKLRNLAD-YADDYRILWKETDETFHEQRIILDCEPKTLKELLKVSIDFKLQGPFRNWFLTHLDTHNSGLRDIYN--EDFKANITSVRLKVVDANPFERKKT
LHKAGIKMQEFE--RGDDYRILWKRINN-AREKFVLLDCPSDILVDVINASIGYNMTGSFNHLFLTNLDTHLSGIDGFYS--RDFTVAVAAVRIRTYVPPPVHDEID
VHNDVVRVRKFH--KDDDFRVMWKSIRG---ERRVVLDCEPNMLVELLNSSTEFGLTGQYNHIFLTNLETYTDHLEELAADNETFAVNITAARLLVNPDPPPYSLPY
IKGPVIKVMRYDLNLNGNYKSVLRRIRK-SEDSRIVVVGSTTGVAELLRQAQQVGIMNEDYTYIIGNLNLHTFDLEEYKYS----EANITGIRMFSPDQEEVRDLME
KSGTVITVLRYDMQLNGNYKQVLRRVRK-SVDNRIVVVGSSETMPEFLNQAQQVGIINEDYKYIIGNLDFHSFDLEEYKYS----EANITGLRLFSPEKMAVKELLM
ISKETLSVRMLDD--SRDPTPLLKEIRD-DKVSTIIIDANASISHLILRKASELGMTSAFYKYILTTMDFPILHLDGIVED----SSNILGFSMFNTSHPFYPEFVR

RLT-KVDQILGN------QTMLPILIYDAVVLFASSARNVIAAMQP-FHPP----NRHCGSSSPWMLGAFIVNEMKTISEDDVEPHFKTENMKLDEYGQRIHFNLEI
VFDNSVDTRFS--------SLGSQLVYDSIVLFYN-ALLEISQRPG-FYIP----NFSCG-RGFWQPGPRLVEQMKQITPKMVKPPFKTQRLQINADGQREDFNLEV
GYVTQRDNIVYESSD-PPRTLIHDLIHDALQLFAQSWRNASFFYPDRMVVPRITCDFAASGGRTWAMGRYLARLMKGTSG-VNNTNFRTSILQFDEDGQRITFNIEV
KLHQELGESEPVNSGSTFITMEMALTYDAVRVIAETTKHLPYQPQM--------LNCSERHDNVQPDGSTFRNYMR--SLEIKEKTITGRIYFEGNVRKGFTFDVIE
KLGYPTDQDE-FRNGSCPITVEMALTYDAVQLFAQTLKNLPFKPMP--------QNCSQRTESVRDDGSSFKNYMR--TLRLTDRLLTGPIYFEGNVRKGYHLDVIE
SLNMSWRENCEASTYLG-PALSAALMFDAVHVVVSAVRELNRSQEIG------VKPLACTSANIWPHGTSLMNYLR-----MVEYDGLTGRVEFNSKGQRTNYTLRI

YKPT--VNEPMMVWTPDN---GIKKRLLN----LELESAGTTQDFSEQRKVYTVVTHYE-EPYFMMKEDHE--NFRGREKYEGYAVDLISKLSELMEFDYEFMIVNG
YNPI--IDRVTHIWNKEFQLVDFEKLRENSTQALKQKRLQNKEDFSQKPIRYTVATRVG-KPYFSWREEPEGVHYEGNERFEGYAVDLIYMLAQECKFDFNFEPVRD
YDPL--DGIGIAIWDPRG-----------------QITQLNVDVKAQKKMIYRVATRIG-PPYFSYNETARELNLTGNALYQGYAVDLIDAIARHVGFEYVFVPVAD
LQTS--GLVKVGTWEEGK-------DFEFQR-PPQAVNFNDIDDGSLVNKTFIVLISVATKPYASLVESID--TLIGNNQFQGYGVDLIKELADKLGFNFTFR-DGG
LQPS--GIVKVGTWDEDR-------QYRPQRLAPTTAQFDSVDN-SLANKTFIILLSVPNKPYAQLVETYK--QLEGNSQYEGYGVDLIKELADKLGFNFTFV-NGG
LEKSRQGHREIGVWYSNR-------------TLAMNATTLDINLSQTLANKTLVVTTILENPYVMRRPNFQ--ALSGNERFEGFCVDMLRELAELLRFRYRLRLVED

(Figure 1-5a cont.)
TM1
N--GKYNPETKQWDGIIRKLIDHHAQIGVCDLTITQMRRSVVDFTVPFMQLGISILHYKSPPEPKNQFAFLEPFAVEVWIYMIFAQLIMTLAFVFIARLSYREWLPP
NKYGSYDANTDEWDGIIRQLIDNNAQIGICDLTITQARRSVVDFTVPFMQLGISILSYKEPPPKADIYAFLNPYNAEVWLFVMIAMMITAFALIFTGRIDQYEWDQP
QQYGKLDKETKQWNGIIGEIINNDAHMGICDLTITQARKTAVDFTVPFMQLGVSILAYKSPHVEKTLDAYLAPFGGEVWIWILISVFVMTFLKTIVARISKMDWENP
NDYGSFNKTTNSTSGMLKEIVEGRADLAITDLTITSEREEVIDFSIPFMNLGIAILYVKPQKAPPALFSFMDPFSSEVWLYLGIAYLGVSLCFFIIGRLSPIEWDNP
NDYGSYNKSTNESTGMLREIMTGRADLAITDLTITSEREQALDFTIPFMNLGIAILYLKPQKATPELFTFMDPFSEEVWWFLGFSFLGVSLSFFILGRLSPSEWDNP
GLYGAPEPNG-SWTGMVGELINRKADLAVAAFTITAEREKVIDFSKPFMTLGISILYRVHMGRKPGYFSFLDPFSPAVWLFMLLAYLAVSCVLFLAARLSPYEWYNP
TM2
TM3
NPAIQD-PDELENIWNVNNSTWLMVGSIMQQGCDILPRGPHMRILTGMWWFFALMMLSTYTANLAAFLTSNKWQSSIKSLQDLIE-QDKVHFGSMRGGSTSLFFSES
VENVNR-EMERQNIWHLSNALWLVLGSMLNQGCDLLPRGLPMRLLTAFWWIFALLISQTYIAKLAAFITSSKIAGDIGSLHDLVD-QNKVQFGTIRGGATSVYFSES
HPCNRD-PEVLENQWRIHNTGWLTVASIMTAGCDILPRSPQVRMFEATWWIFAIIIANSYTANLAAFLTSSKMEGSIANLKDLSA-QKKVKFGTIYGGSTYNLLADS
YPCIEE-PEELENQFTINNSLWFTTGALLQQGSEIAPKALSTRTISAIWWFFTLIMVSSYTANLAAFLTIENPTSPINSVKDLADNKDDVQYGAKRTGSTRNFFSTS
YPCIEE-PEELENQFTLGNSIWFTTGALLQQGSEIGPKALSTRTVASFWWFFTLIVVSSYTANLAAFLTIEKPQSLINSVDDLADNKDGVVYGAKKTGSTRNFFMTS
HPCLRARPHILENQYTLGNSLWFPVGGFMQQGSEIMPRALSTRCVSGVWWAFTLIIISSYTANLAAFLTVQRMEVPVESADDLAD-QTNIEYGTIHAGSTMTFFQNS
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NDTDYQRAWNQMKDFNPSAFTSTNKEGVARVRKEKGGYAFLMETTSLTYNIERNCDLTQIGEQIGEKHYGLAVPLGSDYRTNLSVSILQLSERGELQKMKNKWWKNH
NDTDNRMAWNKMLSFKPDAFTKNNEEGVDRVKLSKGTYAFLMETTNLQYYVQRNCELTQIGESFGEKHYGIAVPLNADFRSNLSVGILRLSERGELFKLRNKWFNSN
NETVYRLAFNLMNNDDPSAYTKDNLEGVDRVRKNRGDYMFLMETTTLEYHREQNCDLRSVGEKFGEKHYAIAVPFGAEYRSNLSVAILKLSERGELYDLKQKWWKNP
EEPIYIKMNEYLNA-HPEMLMENNQQGVDKVKSG-TKYAFLMESTSIEFNTVRECNLTKVGDPLDEKGYGIAMVKNWPYRDKFNKALLELQEQGVLARLKNKWWNEV
AEERYKKMNKFMSE-NPQYLTEDNMEGVNRVKTN-THYAFLMESTSIEYNTKRECNLKKIGDALDEKGYGIAMRKDWPHRGKFNNALLELQEQGVLEKMKNKWWNEV
RYQTYQRMWNYMQSKQPSVFVKSTEEGIARVLNS--RYAFLLESTMNEYHRRLNCNLTQIGGLLDTKGYGIGMPLGSPFRDEITLAILQLQENNRLEILKRKWWEGG
TM4
NV-TCDS-YHEVDGDELSIIELGGVFLVLAGGVLIGVILGIFEFLWNVQNVAVEERVTPWQAFKAELIFALKFWVRKKPMRISS--SSDKSSSRRSS-----GSRRS
ES-TCDSNVPTIDDGQFDMDSVGGLFVVLIVGVVVGLVIGVAEFLWHVQRISVKEKIPPMLALKAEFYFVIRFWLTRKPLHTYR--QSRDSTSTGYSSLEQITSASS
NA-SCFEEPDPDATPDMTFEELRGIFYTLYAGILIAFLIGITEFLVYVQQVALEERLTFKDAFKKEIRFVLCVWNNRKPIVAGTPISSVRTTPRRSLDKSLDRTPKS
GAGVCSAKSDDDGPSELGVDNLSGIYVVLVIGSIISIIISILCWCYFVYKKAKNYEVPFCDALAEEFRIVIRFSENERPLKSAQSIYSRSRNSSQSIESLKTDSEEN
GTGICATKEDAPDATPLDMNNLEGVFFVLLVGSCCALLYGIISWVLFVMKKAHHYRVPLRDALKEEFQFVIDFNNYVRVLKNSASIYSRSRQSSMSVASVAQESQ-RC----PKEEDHRAKGLGMENIGGIFIVLICGLIIAVFVAVMEFIWSTRRSAESEEVSVCQEMLQELRHAVSCRKTSRSRRRRRPGGPSRALLSLRAVREMRLSNGK

(Figure 1-5a cont.)
SKEKSRSKTVS-------------------------------------------------------------------------------AKKKKKTRRIEK------------------------------------------------------------------------------SRRVVIGRSSEEMREMAQGSGSSSGSNNAGRGEKEARV----------------------------------------------------MPVED-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------LYSAGAGGDAGSAHGGPQRLLDDPGPPSGARPAAPTPCTHVRVCQECRRIQALRASGAGAPPRGLGVPAEATSPPRPRPGPAGPRELAEHE
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GluR‐IIA
GluR‐5

-----MRLCPVVIYAFIIIIGFLEGIIALGGDDRNEITVGAIFYENEKE----IELSFDQAFREVNN—-MKFSELRFVTIKRYMPTNDSFLLQQITCELISNGVAAI
MEHGTLLAQPGLWTRDTSWALLYFLCYILPQTAPQVLRIGGIFETVENEPVNVEELAFKFAVTSINRNRTLMPNTTLTYDIQRINLFDSFEASRRACDQLALGVAAL

FGPSSKAASDIVAQIANATGIPHIEYDLKLEATRQEQLNHQMSINVAPSLSVLSRAYFEIIKSNYEWRTFTLIYETPEGLARLQDLMNIQALNSDYVKLRNLADYAD
FGPSHSSSVSAVQSICNALEVPHIQTRWKHPSVDNK---DLFYINLYPDYAAISRAILDLVLY-YNWKTVTVVYEDSTGLIRLQELIKAPSRYNIKIKIRQLPSGNK

DYRILWKETDETFHEQRIILDCEPKTLKELLKVSIDFKLQGPFRNWFLTHLDTHNSGLRDIYNEDFKANITSVRLKVVD----ANPFERKKTRLTKVDQILGNQTML
DAKPLLKEMKK-GKEFYVIFDCSHETAAEILKQILFMGMMTEYYHYFFTTLDLFALDLELYR--YSGVNMTGFRLLNIDNPHVSSIIEKWSMERLQAPPRPETGLLD

PILIYDAVVLFASSARNVIAAMQP--FHPPNRHCGSSSPWMLGAFIVNEMKTISEDDVEPHFKTENMKLDEYGQRIHFNLEIYKPTVNEPMMVWTPDNGIKKRLLNL
GMMTTEAALMYDAVYMVAIASHRASQLTVSSLQCHRHKPWRLGPRFMNLIKEARWDGLTGHITFN--KTNGLRKDFDLDIISLKEEGTEKIGIWNSNSGLNMTDSNK

ELESAGTTQDFSEQRKVYTVVTHYEEPYFMMKEDHENFRGREKYEGYAVDLISKLSELMEFDYEFMIVNGNGKYNP--ETKQWDGIIRKLIDHHAQIGVCDLTITQM
DKSSN---ITDSLANRTLIVTTILEEPYVMYRKSDKPLYGNDRFEGYCLDLLKELSNILGFIYDVKLVP-DGKYGAQNDKGEWNGMVKELIDHRADLAVAPLTITYV
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TM1
TM2
RRSVVDFTVPFMQLGISILHYKSPPEPKNQFAFLEPFAVEVWIYMIFAQLIMTLAFVFIARLSYREWLPPNPAIQDPDELENIWNVNNSTWLMVGSIMQQGCDILPR
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FEFLWNVQNVAVEERVTPWQAFKAELIFALKFWVRKKPMRISSSSDKSSSRRSSGSRRSSKEKSRSKTVS
GEFIYKSRKNNDIEQCLSFNAIMEELGISLKNQKKIKKKSRTKGKSSFTSILTCHQRRTQRKETVA----

Figure 1-5b. Sequence alignment with predicted amino acid sequences of the postsynaptic receptor subunits at Drosophila NMJ (GluRIIA,
GluRIIB, GluRIIC, GluRIID and GluRIIE) and human’s kainate receptor subunits (GluR5, GluR6, GluR7, KA1 and KA2). Sequence
comparisons are achieved to investigate the similarities of the each subunit of Drosophila NMJ and human. Since homologous sequences
are different lengths, gaps are inserted to gain the best match. Clustal W2 is used for sequence analysis.

(Figure 1‐5b cont.)
GluR‐IIB
GluR‐5

MHGLQFLVLLALAIASG------------ANEDTLVIKIGAIFFDTEMKLAD----AFSAALEEVN---AINPALKLDAIKRYVTVDDSIVLQDISCDLIGSGVAAI
MEHGTLLAQPGLWTRDTSWALLYFLCYILPQTAPQVLRIGGIFETVENEPVNVEELAFKFAVTSINRNRTLMPNTTLTYDIQRINLFDSFEASRRACDQLALGVAAL

FGPSSKTNSDIVEVLCNMTGIPHLQFDWHPQQSNRERMNHQLTVNVAPMELFLSAAFSDILASKTFDWKSFTIAYERSSHLIRLQHILAWKQLHKAGIKMQEFERGD
FGPSHSSSVSAVQSICNALEVPHIQTRWKHPSVDNK---DLFYINLYPDYAAISRAILDLVLY--YNWKTVTVVYEDSTGLIRLQELIKAPSRYNIKIKIRQLPSGN

-DYRILWKRINNAREKFVLLDCPSDILVDVINASIGYNMTGSFNHLFLTNLDTHLSGIDGF-YSRDFTVAVAAVRIRTYVPPPVHDEIDVFDNSVDTRFSS-LGSQL
KDAKPLLKEMKKGKEFYVIFDCSHETAAEILKQILFMGMMTEYYHYFFTTLDLFALDLELYRYSGVNMTGFRLLNIDNPHVSSIIEKWSMERLQAPPRPETGLLDGM

VYDSIVLFYNALLEISQRPG----FYIPNFSCGRG-FWQPGPRLVEQMKQITPKMVKPPFKTQRLQINADGQREDFNLEVYNPIIDRVTHIWNKEFQLVDFEKLREN
MTTEAALMYDAVYMVAIASHRASQLTVSSLQCHRHKPWRLGPRFMNLIKEARWDGLTGHITFN----KTNGLRKDFDLDIISLKEEGTEKIG------IWNSNSGLN

STQALKQKRLQNKEDFSQKPIRYTVATRVGKPYFSWREEPEGVHYEGNERFEGYAVDLIYMLAQECKFDFNFEPVRDNKYGSYDANTDEWDGIIRQLIDNNAQIGIC
MTDSNKDKSSNITDSLANR--TLIVTTILEEPYVMYRKSDK--PLYGNDRFEGYCLDLLKELSNILGFIYDVKLVPDGKYGAQND-KGEWNGMVKELIDHRADLAVA
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MKKELSGNSSARWPQMFGGNSREAGMWQRILLLGCMWSAFFMCRSRGQQIN-IGAFFYDDELE----LEKEFMTVVNAINGPESEQTMRFYPLIKRLKPEDGSVTMQ
--------------MEHGTLLAQPGLWTRDTSWALLYFLCYILPQTAPQVLRIGGIFETVENEPVNVEELAFKFAVTSINRNRTLMPNTTLTYDIQRINLFDSFEAS

EHACDLIDNGVAAIFGPSSKAASDIVALVCNSTGIPHIEFDISDEGIQAEKPNHQMTLNLYPAQAILSKAYADIVQNFGWRKFTIVYDADDARAAARLQDLLQLREV
RRACDQLALGVAALFGPSHSSSVSAVQSICNALEVPHIQTRWKHPSVDNKD---LFYINLYPDYAAISRAILDLVLYYNWKTVTVVYEDSTG--LIRLQELIKAPSR

HNDVVRVRKFHK-DDDFRVMWKSIRGER--RVVLDCEPNMLVELLNSSTEFGLTGQYNHIFLTNLETYTDHLEELAADNETFAVNITAARLLVNPDPPPYSLPYGYV
YNIKIKIRQLPSGNKDAKPLLKEMKKGKEFYVIFDCSHETAAEILKQILFMGMMTEYYHYFFTTLDLFALDLELYRYS----GVNMTGFRLLNIDNPHVSSIIEKWS

TQRDNIVYESSDPPRTLIHDLIHDALQLFAQSWRNASFFYPDRMVVPRITCDFAASGGRTWAMGRYLARLMKGTSGVNNTNFRTSILQFDEDGQRITFNIEVYDPLD
MER---LQAPPRPETGLLDGMMTTEAALMYDAVYMVAIAS--HRASQLTVSSLQCHRHKPWRLGPRFMNLIKEAR---WDGLTGHITFNKTNGLRKDFDLDIISLKE

G--IGIAIWDPRGQITQLNVDVKAQKKMIYRVATR-------IGPPYFSYNETARELNLTGNALYQGYAVDLIDAIARHVGFEYVFVPVADQQYGKLDKETKQWNGI
EGTEKIGIWNSNSGLNMTDSNKDKSSNITDSLANRTLIVTTILEEPYVMYRKSDKPL--YGNDRFEGYCLDLLKELSNILGFIYDVKLVPDGKYG-AQNDKGEWNGM
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FGPSHSSSVSAVQSICNALEVPHIQTRWKHPSVDNKDLFYINLYPDYAAISRAILDLVLYYNWKTVTVVYEDSTGLIRLQELIKAPSRYNIKIKIRQLPS-GNKDAK

SVLRRIRKSEDSRIVVVGSTTGVAELLRQAQQVGIMNEDYTYIIGNLNLHTFDLEEYKYSEANITGIRMFSPDQEEVRDLMEKLHQELGESEPVNSG---STFITME
PLLKEMKKGKEFYVIFDCSHETAAEILKQILFMGMMTEYYHYFFTTLDLFALDLELYRYSGVNMTGFRLLNIDNPHVSSIIEKWSMERLQAPPRPETGLLDGMMTTE

MALTYDAVRVIAETTKHLPYQPQMLNCSERHDNVQPDGSTFRNYMRSLEIKEKTITGRIYFEGNVRKGFTFDVIELQTSGLVKVGTWEEGKDFEFQRPPQAVNFNDI
AALMYDAVYMVAIASHRASQLTVSSLQCHRHKPWR-LGPRFMNLIKEARWDGLTGHITFNKTNGLRKDFDLDIISLKEEGTEKIGIWNSNSGLNMTDSNKDKSSNIT

DDGSLVNKTFIVLISVATKPYASLVESIDTLIGNNQFQGYGVDLIKELADKLGFNFTFRDGGNDYGSFNKTTNSTSGMLKEIVEGRADLAITDLTITSEREEVIDFS
D--SLANRTLIVTT-ILEEPYVMYRKSDKPLYGNDRFEGYCLDLLKELSNILGFIYDVKLVPDGKYGAQNDKGEWNGMVKELIDHRADLAVAPLTITYVREKVIDFS
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--MEHGTLLAQPGLWTRDTSWALLYFLCYILPQTAPQVLRIGGIFETVENEPVNVEELAFKFAVTSINRNRTLMPNTTLTYDIQRINLFDSFEASRRACDQLALGVA

GVFGPSSRHTAVHLMSICDAMDIPHIYSYMSENAEG------FNLHPHPADLAKALYSLITEFNWTRFIFLYESAEYLNILNELTTMLGKSGTVITVLRYDMQLNGN
ALFGPSHSSSVSAVQSICNALEVPHIQTRWKHPSVDNKDLFYINLYPDYAAISRAILDLVLYYNWKTVTVVYEDSTGLIRLQELIKAPSRYNIKIKIRQLPSGNK-D

YKQVLRRVRKSVDNRIVVVGSSETMPEFLNQAQQVGIINEDYKYIIGNLDFHSFDLEEYKYSEANITGLRLFSPEKMAVKELLMKLGYPTDQDEFRNGS----CPIT
AKPLLKEMKKGKEFYVIFDCSHETAAEILKQILFMGMMTEYYHYFFTTLDLFALDLELYRYSGVNMTGFRLLNIDNPHVSSIIEKWSMERLQAPPRPETGLLDGMMT
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QFDSVDNSLANKTFIILLSVPNKPYAQLVETYKQLEGNSQYEGYGVDLIKELADKLGFNFTFVNGGNDYGSYNKSTNESTGMLREIMTGRADLAITDLTITSEREQA
KSSNITDSLANRTLIVTT-ILEEPYVMYRKSDKPLYGNDRFEGYCLDLLKELSNILGFIYDVKLVPDGKYGAQNDKGEWNGMVKELIDHRADLAVAPLTITYVREKV
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GPSHSSSANAVQSICNALGVPHIQTRWKHQVSDNK---DSFYVSLYPDFSSLSRAILDLVQF-FKWKTVTVVYDDSTGLIRLQELIKAPSRYNLRLKIRQLPADTKD

YRILWKETDETFHEQRIILDCEPKTLKELLKVSIDFKLQGPFRNWFLTHLDTHNSGLRDIYNEDFKAN-ITSVRLKVVDANPFERKKTRLTKVDQILGNQTMLPILI
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SAGTTQDFSEQRKVYTVVTHYEEPYFMMKEDHENFRGREKYEGYAVDLISKLSELMEFDYEFMIVNGN--GKYNPETKQWDGIIRKLIDHHAQIGVCDLTITQMRRS
PANITDSLSN--RSLIVTTILEEPYVLFKKSDKPLYGNDRFEGYCIDLLRELSTILGFTYEIRLVEDGKYGAQDDANGQWNGMVRELIDHKADLAVAPLAITYVREK
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GPSSKTNSDIVEVLCNMTGIPHLQFDWHPQQSNRERMNHQLTVNVAPMELFLSAAFSDILASKTFDWKSFTIAYERSSHLIRLQHILAWKQLHKAGIKMQEFERG-D
GPSHSSSANAVQSICNALGVPHIQTRWKHQVSD-----NKDSFYVSLYPDFSSLSRAILDLVQFFKWKTVTVVYDDSTGLIRLQELIKAPSRYNLRLKIRQLPADTK

DYRILWKRINNAREKFVLLDCPSDILVDVINASIGYNMTGSFNHLFLTNLDTHLSGIDGFYSRDFTVAVAAVR--IRTYVPPPVHDEIDVFDNSVDTRFSSLGSQLV
DAKPLLKEMKRGKEFHVIFDCSHEMAAGILKQALAMGMMTEYYHYIFTTLDLFALDVEPYRYSGVNMTGFRILNTENTQVSSIIEKWSMERLQAPPKPDSGLLDGFM

YDSIVLFYNALLEIS----QRPGFYIPNFSCGRG-FWQPGPRLVEQMKQITPKMVKPPFKTQRLQINADGQREDFNLEVYNPIIDRVTHIWNKEFQLVDFEKLRENS
TTDAALMYDAVHVVSVAVQQFPQMTVSSLQCNRHKPWRFGTRFMSLIKEAHWEGLTGRITFN----KTNGLRTDFDLDVISLKEEGLEKIG------TWDPASGLNM

TQALKQKRLQNKEDFSQKPIRYTVATRVGKPYFSWREEPEGVHYEGNERFEGYAVDLIYMLAQECKFDFNFEPVRDNKYGSYDANTDEWDGIIRQLIDNNAQIGICD
TESQKGKPANITDSLSNR--SLIVTTILEEPYVLFKKSDK--PLYGNDRFEGYCIDLLRELSTILGFTYEIRLVEDGKYGAQDDANGQWNGMVRELIDHKADLAVAP
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IGIAIWDPRGQITQLNVDVKAQKKMIYRVATR-------IGPPYFSYNETARELNLTGNALYQGYAVDLIDAIARHVGFEYVFVPVADQQYGKLDKETKQWNGIIGE
EKIGTWDPASGLNMTESQKGKPANITDSLSNRSLIVTTILEEPYVLFKKSD--KPLYGNDRFEGYCIDLLRELSTILGFTYEIRLVEDGKYGAQDDANGQWNGMVRE
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GWLTVASIMTAGCDILPRSPQVRMFEATWWIFAIIIANSYTANLAAFLTSSKMEGSIANLKDLSAQKKVKFGTIYGGSTYNLLADSNETVYRLAFNLMNNDDPSAYT
FWFGVGALMQQGSELMPKALSTRIVGGIWWFFTLIIISSYTANLAAFLTVERMESPIDSADDLAKQTKIEYGAVEDGATMTFFKKSKISTYDKMWAFMSSRRQSVLV

KDNLEGVDRVRKNRGDYMFLMETTTLEYHREQNCDLRSVGEKFGEKHYAIAVPFGAEYRSNLSVAILKLSERGELYDLKQKWWKNPNASCFEEPDPDATPDMTFEEL
KSNEEGIQRVLTS--DYAFLMESTTIEFVTQRNCNLTQIGGLIDSKGYGVGTPMGSPYRDKITIAILQLQEEGKLHMMKEKWWR---GNGCPEEESKEASALGVQNI
TM4
RGIFYTLYAGILIAFLIGITEFLVYVQQVALEERLTFKDAFKKEIRFVLCVWNNRKPIVAGTPISSVRTTPRRSLDKSLDRTPKSSRRVVIGRSSEEMREMAQGSGS
GGIFIVLAAGLVLSVFVAVGEFLYKSKKNAQLEKE-----------------------------SSIWLVPPYHPDTV----------------------------SSGSNNAGRGEKEARV
----------------

(Figure 1‐5b cont.)
GluR‐IID
GluR‐6

--MHFCWISLIILSLSRVQAQFYGGNAYEASSGQSIRLG----LITDDATDRIRQTFEHAISVVNN----ELGVPLVGETEQVAYGNSVQAFAQLCRLMQSGVGAVF
MKIIFPILSNPVFRRTVKLLLCLLWIGYSQGTTHVLRFGGIFEYVESGPMGAEELAFRFAVNTINRNRTLLPNTTLTYDTQKINLYDSFEASKKACDQLSLGVAAIF

GPAARHTASHLLNACDSKDIPFIYPHLSWGSNPDG----FNLHPSPEDIANALYDIVNQFEWSRFIFCYESAEYLKILDHLMTRYGIKGPVIKVMRYDLNLNGNYKS
GPSHSSSANAVQSICNALGVPHIQTRWKHQVSDNKDSFYVSLYPDFSSLSRAILDLVQFFKWKTVTVVYDDSTGLIRLQELIKAPSRYNLRLKIRQLPADTK-DAKP

VLRRIRKSEDSRIVVVGSTTGVAELLRQAQQVGIMNEDYTYIIGNLNLHTFDLEEYKYSEANITGIRMFSPDQEEVRDLMEKLHQELGESEPVNSG---STFITMEM
LLKEMKRGKEFHVIFDCSHEMAAGILKQALAMGMMTEYYHYIFTTLDLFALDVEPYRYSGVNMTGFRILNTENTQVSSIIEKWSMERLQAPPKPDSGLLDGFMTTDA

ALTYDAVRVIAETTKHLPYQPQMLNCSERHDNVQPDGSTFRNYMRSLEIKEKTITGRIYFEGN--VRKGFTFDVIELQTSGLVKVGTWEEGKDFEFQRPPQAVNFND
ALMYDAVHVVSVAVQQFP---QMTVSSLQCNRHKPWRFGTRFMSLIKEAHWEGLTGRITFNKTNGLRTDFDLDVISLKEEGLEKIGTWDPASGLNMTESQKGKPANI

IDDGSLVNKTFIVLISVATKPYASLVESIDTLIGNNQFQGYGVDLIKELADKLGFNFTFRDGGN-DYGSFNKTTNSTSGMLKEIVEGRADLAITDLTITSEREEVID
TDS---LSNRSLIVTTILEEPYVLFKKSDKPLYGNDRFEGYCIDLLRELSTILGFTYEIRLVEDGKYGAQDDANGQWNGMVRELIDHKADLAVAPLAITYVREKVID
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TM1
TM2
FSIPFMNLGIAILYVKPQKAPPALFSFMDPFSSEVWLYLGIAYLGVSLCFFIIGRLSPIEWDNPYPCIEEPEELENQFTINNSLWFTTGALLQQGSEIAPKALSTRT
FSKPFMTLGISILYRKPNGTNPGVFSFLNPLSPDIWMYILLAYLGVSCVLFVIARFSPYEWYNPHPCNPDSDVVENNFTLLNSFWFGVGALMQQGSELMPKALSTRI
TM3
ISAIWWFFTLIMVSSYTANLAAFLTIENPTSPINSVKDLADNKDDVQYGAKRTGSTRNFFSTSEEPIYIKMNEYLN-AHPEMLMENNQQGVDKVKSGTKYAFLMEST
VGGIWWFFTLIIISSYTANLAAFLTVERMESPIDSADDLAKQT-KIEYGAVEDGATMTFFKKSKISTYDKMWAFMSSRRQSVLVKSNEEGIQRVLT-SDYAFLMEST
TM4
SIEFNTVRECNLTKVGDPLDEKGYGIAMVKNWPYRDKFNKALLELQEQGVLARLKNKWWNEVGAGVCSAKSDDDGPSELGVDNLSGIYVVLVIGSIISIIISILCWC
TIEFVTQRNCNLTQIGGLIDSKGYGVGTPMGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNGCPEEESKE----ASALGVQNIGGIFIVLAAGLVLSVFVAVGEFL

YFVYKKAKNYEVPFCDALAEEFRIVIRFSENERPLKSAQSIYSRSRNSSQSIESLKTDSEENMPVED
YKSKKNAQ--------------------------LEKESSIWLVPPYHPDTV---------------

(Figure 1‐5b cont.)
GluR‐IIE
GluR‐6

-----------MFFNHFVILWSLFSIHISVNWAQYENFGGYDNYQSLESVPIGLLTDQNTEQMNIVFDHAIDVANQEVGTSLTSLKEEVNYGDAYQSYGKLCRMLET
MKIIFPILSNPVFRRTVKLLLCLLWIGYSQGTTHVLRFGG--IFEYVESGPMGAEELAFRFAVNTINRNRTLLPN----TTLTYDTQKINLYDSFEASKKACDQLSL

GIAGVFGPSSRHTAVHLMSICDAMDIPHIYSYMSENAEG------FNLHPHPADLAKALYSLITEFNWTRFIFLYESAEYLNILNELTTMLGKSGTVITVLRYDMQL
GVAAIFGPSHSSSANAVQSICNALGVPHIQTRWKHQVSDNKDSFYVSLYPDFSSLSRAILDLVQFFKWKTVTVVYDDSTGLIRLQELIKAPSRYNLRLKIRQLPADT

NGNYKQVLRRVRKSVDNRIVVVGSSETMPEFLNQAQQVGIINEDYKYIIGNLDFHSFDLEEYKYSEANITGLRLFSPEKMAVKELLMKLGYPTDQDEFRNGS----C
K-DAKPLLKEMKRGKEFHVIFDCSHEMAAGILKQALAMGMMTEYYHYIFTTLDLFALDVEPYRYSGVNMTGFRILNTENTQVSSIIEKWSMERLQAPPKPDSGLLDG

PITVEMALTYDAVQLFAQTLKNLPFKPMPQNCSQRTESVRDDGSSFKNYMRTLRLTDRLLTGPIYFEGN--VRKGYHLDVIELQPSGIVKVGTWDEDRQYRPQRLAP
FMTTDAALMYDAVHVVSVAVQQFPQMTVSSLQCNRHKPWR-FGTRFMSLIKEAHWEG--LTGRITFNKTNGLRTDFDLDVISLKEEGLEKIGTWDPASGLN--MTES

TTAQFDSVDNSLANKTFIILLSVPNKPYAQLVETYKQLEGNSQYEGYGVDLIKELADKLGFNFTFVNGGN-DYGSYNKSTNESTGMLREIMTGRADLAITDLTITSE
QKGKPANITDSLSNRSLIVTT-ILEEPYVLFKKSDKPLYGNDRFEGYCIDLLRELSTILGFTYEIRLVEDGKYGAQDDANGQWNGMVRELIDHKADLAVAPLAITYV
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TM1
TM2
REQALDFTIPFMNLGIAILYLKPQKATPELFTFMDPFSEEVWWFLGFSFLGVSLSFFILGRLSPSEWDNPYPCIEEPEELENQFTLGNSIWFTTGALLQQGSEIGPK
REKVIDFSKPFMTLGISILYRKPNGTNPGVFSFLNPLSPDIWMYILLAYLGVSCVLFVIARFSPYEWYNPHPCNPDSDVVENNFTLLNSFWFGVGALMQQGSELMPK
TM3
ALSTRTVASFWWFFTLIVVSSYTANLAAFLTIEKPQSLINSVDDLADNKDGVVYGAKKTGSTRNFFMTSAEERYKKMNKFMSENPQ-YLTEDNMEGVNRVKTNTHYA
ALSTRIVGGIWWFFTLIIISSYTANLAAFLTVERMESPIDSADDLAKQTK-IEYGAVEDGATMTFFKKSKISTYDKMWAFMSSRRQSVLVKSNEEGIQRVLT-SDYA
TM4
FLMESTSIEYNTKRECNLKKIGDALDEKGYGIAMRKDWPHRGKFNNALLELQEQGVLEKMKNKWWNEVGTGICATKEDAPDATPLDMNNLEGVFFVLLVGSCCALLY
FLMESTTIEFVTQRNCNLTQIGGLIDSKGYGVGTPMGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNG----CPEEESKEASALGVQNIGGIFIVLAAG-------

GIISWVLFVMKKAHHYRVPLRDALKEEFQFVIDFNNYVRVLKNSASIYSRSRQSSMSVASVAQESQ
--LVLSVFVAVGEFLYKSKKNAQLEKESSIWLVPPYHPDTV-------------------------

(Figure 1‐5b cont.)
GluR‐IIA
GluR‐7

----MRLCPVVIYAFIIIIGFLEGIIALGGDDRNEITVGAIFYENE---------KEIELSFDQAFREVNNMKFSELRFVTIKRYMPTNDSFLLQQITCELISNGVA
MTAPWRRLRSLVWEYWAGLLVCAFWIPDSRGMPHVIRIGGIFEYADGPNAQVMNAEEHAFRFSANIINRNRTLLPNTTLTYDIQRIHFHDSFEATKKACDQLALGVV

AIFGPSSKAASDIVAQIANATGIPHIEYDLKLEATRQEQLNHQMSINVAPSLSVLSRAYFEIIKSNYEWRTFTLIYETPEGLARLQDLMNIQALNSDYVKLRNLADY
AIFGPSQGSCTNAVQSICNALEVPHIQLRWKHHPLDNK---DTFYVNLYPDYASLSHAILDLVQY-LKWRSATVVYDDSTGLIRLQELIMAPSRYNIRLKIRQLPID

ADDYRILWKETDETFHEQRIILDCEPKTLKELLKVSIDFKLQGPFRNWFLTHLDTHNSGLRDIYNEDFKAN---ITSVRLKVVDANPFERKKTRLTKVDQILGNQTM
SDDSRPLLKEMKR-GREFRIIFDCSHTMAAQILKQAMAMGMMTEYYHFIFTTLDLYALDLEPYRYSGVNLTGFRILNVDNPHVSAIVEKWSMERLQAAPRSESGLLD

LPILIYDAVVLFASSARNVIAAMQPFHPPN-RHCGSSSPWMLGAFIVNEMKTISEDDVEPHFKTENMKLDEYGQRIHFNLEIYKPTVN--EPMMVWTPDNGIKKRLL
GVMMTDAALLYDAVHIVSVCYQRAPQMTVNSLQCHRHKAWRFGGRFMNFIKEAQWEGLTGRIVFN----KTSGLRTDFDLDIISLKEDGLEKVGVWSPADGLN---I

NLELESAGTTQDFSEQRKVYTVVTHYEEPYFMMKEDHENFRGREKYEGYAVDLISKLSELMEFDYEFMIVNGNGKYNP--ETKQWDGIIRKLIDHHAQIGVCDLTIT
TEVAKGRGPNVTDSLTNRSLIVTTVLEEPFVMFRKSDRTLYGNDRFEGYCIDLLKELAHILGFSYEIRLVE-DGKYGAQDDKGQWNGMVKELIDHKADLAVAPLTIT
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TM1
TM2
QMRRSVVDFTVPFMQLGISILHYKSPPEPKNQFAFLEPFAVEVWIYMIFAQLIMTLAFVFIARLSYREWLPPNPAIQDPDELENIWNVNNSTWLMVGSIMQQGCDIL
HVREKAIDFSKPFMTLGVSILYRKPNGTNPSVFSFLNPLSPDIWMYVLLAYLGVSCVLFVIARFSPYEWYDAHPCNPGSEVVENNFTLLNSFWFGMGSLMQQGSELM
TM3
PRGPHMRILTGMWWFFALMMLSTYTANLAAFLTSNKWQSSIKSLQDLIEQDKVHFGSMRGGSTSLFFSESNDTDYQRAWNQMKDFNPSAFTSTNKEGVARVRKEKGG
PKALSTRIIGGIWWFFTLIIISSYTANLAAFLTVERMESPIDSADDLAKQTKIEYGAVKDGATMTFFKKSKISTFEKMWAFMSSK-PSALVKNNEEGIQRALT--AD
TM4
YAFLMETTSLTYNIERNCDLTQIGEQIGEKHYGLAVPLGSDYRTNLSVSILQLSERGELQKMKNKWWKNHNVTCDSYHEVDGDELSIIELGGVFLVLAGGVLIGVIL
YALLMESTTIEYVTQRNCNLTQIGGLIDSKGYGIGTPMGSPYRDKITIAILQLQEEDKLHIMKEKWWRGS--GCPEEENKEASALGIQKIGGIFIVLAAGLVLSVLV

GIFEFLWNVQNVAVEERVTPWQAFKAELIFALKFWVRKKPMRISSSSDKSSSRRSSGSRRSSKEKSRSKTVS
AVGEFVYKLRKTAEREQVS---------------------------------LRAWSLHRMGNGDSR-----

(Figure 1‐5b cont.)
GluR‐IIB
GluR‐7

-------MHGLQFLVLLALAIASGANEDT----LVIKIGAIFFDTEMKLADAFSAALEEVNAIN----------PALKLDAIKRYVTVDDSIVLQDISCDLIGSGVA
MTAPWRRLRSLVWEYWAGLLVCAFWIPDSRGMPHVIRIGGIFEYADGPNAQVMNAEEHAFRFSANIINRNRTLLPNTTLTYDIQRIHFHDSFEATKKACDQLALGVV

AIFGPSSKTNSDIVEVLCNMTGIPHLQFDWHPQQSNRERMNHQLTVNVAPMELFLSAAFSDILASKTFDWKSFTIAYERSSHLIRLQHILAWKQLHKAGIKMQEFER
AIFGPSQGSCTNAVQSICNALEVPHIQLRWKHHPLDNK---DTFYVNLYPDYASLSHAILDLVQ--YLKWRSATVVYDDSTGLIRLQELIMAPSRYNIRLKIRQLPI

-GDDYRILWKRINNAREKFVLLDCPSDILVDVINASIGYNMTGSFNHLFLTNLDTHLSGIDGFYSRDFTVAVAAVRIRTYVPPPVHDEIDVFDNS----VDTRFSSL
DSDDSRPLLKEMKRGREFRIIFDCSHTMAAQILKQAMAMGMMTEYYHFIFTTLDLYALDLEPYRYSG--VNLTGFRILNVDNPHVSAIVEKWSMERLQAAPRSESGL

GSQLVYDSIVLFYNALLEIS----QRPGFYIPNFSCGRG-FWQPGPRLVEQMKQITPKMVKPPFKTQRLQINADGQREDFNLEVYNPIIDRVTHIWNKEFQLVDFEK
LDGVMMTDAALLYDAVHIVSVCYQRAPQMTVNSLQCHRHKAWRFGGRFMNFIKEAQWEGLTGRIVFN----KTSGLRTDFDLDIISLKEDGLEKVG------VWSPA

LRENSTQALKQKRLQNKEDFSQKPIRYTVATRVGKPYFSWREEPEGVHYEGNERFEGYAVDLIYMLAQECKFDFNFEPVRDNKYGSYDANTDEWDGIIRQLIDNNAQ
DGLNITEVAKGRGPNVTDSLTNR--SLIVTTVLEEPFVMFRKSDR--TLYGNDRFEGYCIDLLKELAHILGFSYEIRLVEDGKYGAQDD-KGQWNGMVKELIDHKAD
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TM1
TM2
IGICDLTITQARRSVVDFTVPFMQLGISILSYKEPPPKADIYAFLNPYNAEVWLFVMIAMMITAFALIFTGRIDQYEWDQPVENVNREMERQNIWHLSNALWLVLGS
LAVAPLTITHVREKAIDFSKPFMTLGVSILYRKPNGTNPSVFSFLNPLSPDIWMYVLLAYLGVSCVLFVIARFSPYEWYDAHPCNPGSEVVENNFTLLNSFWFGMGS
TM3
MLNQGCDLLPRGLPMRLLTAFWWIFALLISQTYIAKLAAFITSSKIAGDIGSLHDLVDQNKVQFGTIRGGATSVYFSESNDTDNRMAWNKMLSFKPDAFTKNNEEGV
LMQQGSELMPKALSTRIIGGIWWFFTLIIISSYTANLAAFLTVERMESPIDSADDLAKQTKIEYGAVKDGATMTFFKKSKISTFEKMW-AFMSSKPSALVKNNEEGI

DRVKLSKGTYAFLMETTNLQYYVQRNCELTQIGESFGEKHYGIAVPLNADFRSNLSVGILRLSERGELFKLRNKWFNSNESTCDSNVPTIDDGQFDMDSVGGLFVVL
QRALTAD--YALLMESTTIEYVTQRNCNLTQIGGLIDSKGYGIGTPMGSPYRDKITIAILQLQEEDKLHIMKEKWWRGSGCPEEENK---EASALGIQKIGGIFIVL
TM4
IVGVVVGLVIGVAEFLWHVQRISVKEKIPPMLALKAEFYFVIRFWLTRKPLHTYRQSRDSTSTGYSSLEQITSASSAKKKKKTRRIEK
AAGLVLSVLVAVGEFVYKLRKTAEREQVS----------------LRAWSLHRMGNGDSR----------------------------

(Figure 1‐5b cont.)
GluR‐IIC
GluR‐7

MKKELSGNSSARWPQMFGGNSREAGMWQRILLLGCMWSAFFMCRSRGQQINIGAFFYDDELELEKEFMTVVNAINGPESEQTMRFYPLIKRLKPEDGSVTMQEHACD
MTAPWRRLRSLVWEYWAG-------LLVCAFWIPDSRGMPHVIRIGGIFEYADGPNAQVMNAEEHAFRFSANIINRNRTLLPNTTLTYDIQRIHFHDSFEATKKACD

LIDNGVAAIFGPSSKAASDIVALVCNSTGIPHIEFDISDEGIQAEKPNHQMTLNLYPAQAILSKAYADIVQNFGWRKFTIVYDADDARAAARLQDLLQLREVHNDVV
QLALGVVAIFGPSQGSCTNAVQSICNALEVPHIQLRWKHHPLDNK---DTFYVNLYPDYASLSHAILDLVQYLKWRSATVVYDDSTG--LIRLQELIMAPSRYNIRL

RVRKFHKD-DDFRVMWKSIRGER--RVVLDCEPNMLVELLNSSTEFGLTGQYNHIFLTNLETYTDHLEELAADNETFAVNITAARLLVNPDPPPYSLPYGYVTQRDN
KIRQLPIDSDDSRPLLKEMKRGREFRIIFDCSHTMAAQILKQAMAMGMMTEYYHFIFTTLDLYALDLEPYRYS----GVNLTGFRILNVDNPHVSAIVEKWSMER--

IVYESSDPPRTLIHDLIHDALQLFAQSWRNASFFYPDRMVVPRITCDFAASGGRTWAMGRYLARLMKGTSGVNNTNFRTSILQFDEDGQRITFNIEVYDPLDG--IG
-LQAAPRSESGLLDGVMMTDAALLYDAVHIVSVCYQR--APQMTVNSLQCHRHKAWRFG---GRFMNFIKEAQWEGLTGRIVFNKTSGLRTDFDLDIISLKEDGLEK

IAIWDPRGQITQLNVDVKAQKKMIYRVATR-------IGPPYFSYNETARELNLTGNALYQGYAVDLIDAIARHVGFEYVFVPVADQQYGKLDKETKQWNGIIGEII
VGVWSPADGLNITEVAKGRGPNVTDSLTNRSLIVTTVLEEPFVMFRKSDRTL--YGNDRFEGYCIDLLKELAHILGFSYEIRLVEDGKYGAQD-DKGQWNGMVKELI
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TM1
NNDAHMGICDLTITQARKTAVDFTVPFMQLGVSILAYKSPHVEKTLDAYLAPFGGEVWIWILISVFVMTFLKTIVARISKMDWENPHPCNRDPEVLENQWRIHNTGW
DHKADLAVAPLTITHVREKAIDFSKPFMTLGVSILYRKPNGTNPSVFSFLNPLSPDIWMYVLLAYLGVSCVLFVIARFSPYEWYDAHPCNPGSEVVENNFTLLNSFW
TM2
TM3
LTVASIMTAGCDILPRSPQVRMFEATWWIFAIIIANSYTANLAAFLTSSKMEGSIANLKDLSAQKKVKFGTIYGGSTYNLLADSNETVYRLAFNLMNNDDPSAYTKD
FGMGSLMQQGSELMPKALSTRIIGGIWWFFTLIIISSYTANLAAFLTVERMESPIDSADDLAKQTKIEYGAVKDGATMTFFKKSKISTFEKMWAFMSSK-PSALVKN

NLEGVDRVRKNRGDYMFLMETTTLEYHREQNCDLRSVGEKFGEKHYAIAVPFGAEYRSNLSVAILKLSERGELYDLKQKWWKNPNASCFEEPDPDATPDMTFEELRG
NEEGIQRALT--ADYALLMESTTIEYVTQRNCNLTQIGGLIDSKGYGIGTPMGSPYRDKITIAILQLQEEDKLHIMKEKWWRG--SGCPEEENKEAS-ALGIQKIGG
TM4
IFYTLYAGILIAFLIGITEFLVYVQQVALEERLTFKDAFKKEIRFVLCVWNNRKPIVAGTPISSVRTTPRRSLDKSLDRTPKSSRRVVIGRSSEEMREMAQGSGSSS
IFIVLAAGLVLSVLVAVGEFVYKLRKTAEREQVSLR-------------------------------------AWSLHRMGNGDSR--------------------GSNNAGRGEKEARV
--------------

(Figure 1‐5b cont.)
GluR‐IID
GluR‐7

MHFCWISLIILSLSRVQAQFYGGNAYEASSGQ--SIRLG---LITDDATDRIRQTFEHAISVVNNELG--------VPLVGETEQVAYGNSVQAFAQLCRLMQSGVG
MTAPWRRLRSLVWEYWAGLLVCAFWIPDSRGMPHVIRIGGIFEYADGPNAQVMNAEEHAFRFSANIINRNRTLLPNTTLTYDIQRIHFHDSFEATKKACDQLALGVV

AVFGPAARHTASHLLNACDSKDIPFIYPHLSWGSNPDG----FNLHPSPEDIANALYDIVNQFEWSRFIFCYESAEYLKILDHLMTRYGIKGPVIKVMRYDLNLNGN
AIFGPSQGSCTNAVQSICNALEVPHIQLRWKHHPLDNKDTFYVNLYPDYASLSHAILDLVQYLKWRSATVVYDDSTGLIRLQELIMAPSRYNIRLKIRQLPIDSD-D

YKSVLRRIRKSEDSRIVVVGSTTGVAELLRQAQQVGIMNEDYTYIIGNLNLHTFDLEEYKYSEANITGIRMFSPDQEEVRDLMEKLHQELGESEPVNSG---STFIT
SRPLLKEMKRGREFRIIFDCSHTMAAQILKQAMAMGMMTEYYHFIFTTLDLYALDLEPYRYSGVNLTGFRILNVDNPHVSAIVEKWSMERLQAAPRSESGLLDGVMM

MEMALTYDAVRVIAETTKHLPYQPQMLNCSERHDNVQPDGSTFRNYMRSLEIKEKTITGRIYFEGNVRKGFTFDVIELQTSGLVKVGTWEEGKDFEFQRPPQAVNFN
TDAALLYDAVHIVSVCYQRAPQMTVNSLQCHRHKAWRFGG-RFMNFIKEAQWEGLTGRIVFNKTSGLRTDFDLDIISLKEDGLEKVGVWSPADGLNITEVAKGRGPN

DIDDGSLVNKTFIVLISVATKPYASLVESIDTLIGNNQFQGYGVDLIKELADKLGFNFTFRDGGNDYGSFNKTTNSTSGMLKEIVEGRADLAITDLTITSEREEVID
VTDS---LTNRSLIVTTVLEEPFVMFRKSDRTLYGNDRFEGYCIDLLKELAHILGFSYEIRLVEDGKYGAQDDKGQWNGMVKELIDHKADLAVAPLTITHVREKAID
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TM1
TM2
FSIPFMNLGIAILYVKPQKAPPALFSFMDPFSSEVWLYLGIAYLGVSLCFFIIGRLSPIEWDNPYPCIEEPEELENQFTINNSLWFTTGALLQQGSEIAPKALSTRT
FSKPFMTLGVSILYRKPNGTNPSVFSFLNPLSPDIWMYVLLAYLGVSCVLFVIARFSPYEWYDAHPCNPGSEVVENNFTLLNSFWFGMGSLMQQGSELMPKALSTRI
TM3
ISAIWWFFTLIMVSSYTANLAAFLTIENPTSPINSVKDLADNKDDVQYGAKRTGSTRNFFSTSEEPIYIKMNEYLNAHPEMLMENNQQGVDKVKSGTKYAFLMESTS
IGGIWWFFTLIIISSYTANLAAFLTVERMESPIDSADDLAKQT-KIEYGAVKDGATMTFFKKSKISTFEKMWAFMSSKPSALVKNNEEGIQRALT-ADYALLMESTT
TM4
IEFNTVRECNLTKVGDPLDEKGYGIAMVKNWPYRDKFNKALLELQEQGVLARLKNKWWNEVGAGVCSAKSDDDGPSELGVDNLSGIYVVLVIGSIISIIISILCWCY
IEYVTQRNCNLTQIGGLIDSKGYGIGTPMGSPYRDKITIAILQLQEEDKLHIMKEKWWRGSGC----PEEENKEASALGIQKIGGIFIVLAAGLVLSVLVAVGEFVY

FVYKKAKNYEVPFCDALAEEFRIVIRFSENERPLKSAQSIYSRSRNSSQSIESLKTDSEENMPVED
KLRKTAE----------------------REQVSLRAWSLHRMGNGDSR-----------------

(Figure 1‐5b cont.)
GluR‐IIE
GluR‐7

---MFFNHFVILWSLFSIHISVNWAQYENFGGYDNYQS---LESVPIGLLTDQNTEQMNIVFDHAIDVANQEVG--TSLTSLKEEVNYGDAYQSYGKLCRMLETGIA
MTAPWRRLRSLVWEYWAGLLVCAFWIPDSRGMPHVIRIGGIFEYADGPNAQVMNAEEHAFRFSANIINRNRTLLPNTTLTYDIQRIHFHDSFEATKKACDQLALGVV

GVFGPSSRHTAVHLMSICDAMDIPHIYSYMSENAEG------FNLHPHPADLAKALYSLITEFNWTRFIFLYESAEYLNILNELTTMLGKSGTVITVLRYDMQLNGN
AIFGPSQGSCTNAVQSICNALEVPHIQLRWKHHPLDNKDTFYVNLYPDYASLSHAILDLVQYLKWRSATVVYDDSTGLIRLQELIMAPSRYNIRLKIRQLPIDSD-D

YKQVLRRVRKSVDNRIVVVGSSETMPEFLNQAQQVGIINEDYKYIIGNLDFHSFDLEEYKYSEANITGLRLFSPEKMAVKELLMKLGYPTDQDEFRNGS----CPIT
SRPLLKEMKRGREFRIIFDCSHTMAAQILKQAMAMGMMTEYYHFIFTTLDLYALDLEPYRYSGVNLTGFRILNVDNPHVSAIVEKWSMERLQAAPRSESGLLDGVMM

VEMALTYDAVQLFAQTLKNLPFKPMPQNCSQRTESVRDDGSSFKNYMRTLRLTDRLLTGPIYFEGN--VRKGYHLDVIELQPSGIVKVGTWDEDRQYRPQRLAPTTA
TDAALLYDAVHIVSVCYQRAPQMTVNSLQCHRHKAWRFGG-RFMNFIKEAQWEG--LTGRIVFNKTSGLRTDFDLDIISLKEDGLEKVGVWSPADGLNITEVAK--G

QFDSVDNSLANKTFIILLSVPNKPYAQLVETYKQLEGNSQYEGYGVDLIKELADKLGFNFTFVNGGNDYGSYNKSTNESTGMLREIMTGRADLAITDLTITSEREQA
RGPNVTDSLTNRSLIVTT-VLEEPFVMFRKSDRTLYGNDRFEGYCIDLLKELAHILGFSYEIRLVEDGKYGAQDDKGQWNGMVKELIDHKADLAVAPLTITHVREKA
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TM1
TM2
LDFTIPFMNLGIAILYLKPQKATPELFTFMDPFSEEVWWFLGFSFLGVSLSFFILGRLSPSEWDNPYPCIEEPEELENQFTLGNSIWFTTGALLQQGSEIGPKALST
IDFSKPFMTLGVSILYRKPNGTNPSVFSFLNPLSPDIWMYVLLAYLGVSCVLFVIARFSPYEWYDAHPCNPGSEVVENNFTLLNSFWFGMGSLMQQGSELMPKALST
TM3
RTVASFWWFFTLIVVSSYTANLAAFLTIEKPQSLINSVDDLADNKDGVVYGAKKTGSTRNFFMTSAEERYKKMNKFMSENPQYLTEDNMEGVNRVKTNTHYAFLMES
RIIGGIWWFFTLIIISSYTANLAAFLTVERMESPIDSADDLAKQTK-IEYGAVKDGATMTFFKKSKISTFEKMWAFMSSKPSALVKNNEEGIQRALT-ADYALLMES
TM4
TSIEYNTKRECNLKKIGDALDEKGYGIAMRKDWPHRGKFNNALLELQEQGVLEKMKNKWWNEVGTGICATKEDAPDATPLDMNNLEGVFFVLLVGSCCALLYGIISW
TTIEYVTQRNCNLTQIGGLIDSKGYGIGTPMGSPYRDKITIAILQLQEEDKLHIMKEKWWRGSG----CPEEENKEASALGIQKIGGIFIVLAAGLVLSVLVAVGEF

VLFVMKKAHHYRVPLRDALKEEFQFVIDFNNYVRVLKNSASIYSRSRQSSMSVASVAQESQ
VYKLRKTAEREQVSLR----------------AWSLHRMGNGDSR----------------

(Figure 1‐5b cont.)
GluR‐IIA MRLCPVVIYAFIIIIGFLEGIIALGGDDRNEITVGAIFYENEKE-IELSFDQAFREVNNMKFSELRFVTIKRYMPTNDSFLLQQITCELISNGVAAIFGPSSK-AAS
KA1
---MPRVSAPLVLLPAWLVMVACSPHSLRIAAILDDPMECSRGERLSITLAKNRINRAPERLGKAKVEVDIFELLRDSEYETAETMCQILPKGVVAVLGPSSSPASS

DIVAQIANATGIPHIEYDLKLEATRQEQLNHQMSINVAPSLSVLSRAYFEIIKSNYEWRTFTLIYETPEGLARLQDLMNIQALNSDYVKLRNLADYADDYRILWKET
SIISNICGEKEVPHFKVAP--EEFVKFQFQRFTTLNLHPSNTDISVAVAGILN-FFNCTTACLICAKAECLLNLEKLLRQFLISKDTLSVRMLDDTRDPTPLLKEIR

DETFHEQRIILDCEPKTLKELLKVSIDFKLQGPFRNWFLTHLDTHNSGLRDIYNEDFKAN---ITSVRLKVVDANPFERKKTRLTKVDQILGNQTMLPILIYDAVVL
DD--KTATIIIHANASMSHTILLKAAELGMVSAYYTYIFTNLEFSLQRMDSLVDDRVNILGFSIFNQSHAFFQEFAQSLNQSWQENCDHVPFTGPALSSALLFDAVY

FASSARNVIAAMQPFHPPNRHCGSSSPWMLGAFIVNEMKTISEDDVEPHFKTENMKLDEYGQRIHFNLEIYKPTVN--EPMMVWTPDNGIKKRLLNLELESAGTTQD
AVVTAVQELNRSQEIGVKPLSCGSAQIWQHGTSLMNYLRMVELEGLTGHIEFN-----SKGQRSNYALKILQFTRNGFRQIGQWHVAEGLS---MDSHLYASNISDT

FSEQRKVYTVVTHYEEPYFMMKEDHENFRGREKYEGYAVDLISKLSELMEFDYEFMIVNGNGKYNPETK-QWDGIIRKLIDHHAQIGVCDLTITQMRRSVVDFTVPF
LFN--TTLVVTTILENPYLMLKGNHQEMEGNDRYEGFCVDMLKELAEILRFNYKIRLVGDGVYGVPEANGTWTGMVGELIARKADLAVAGLTITAEREKVIDFSKPF
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TM1
TM2
MQLGISILHYKSPPEPKNQFAFLEPFAVEVWIYMIFAQLIMTLAFVFIARLSYREWLPPNPAIQ-DPDELENIWNVNNSTWLMVGSIMQQGCDILPRGPHMRILTGM
MTLGISILYRVHMGRKPGYFSFLDPFSPGVWLFMLLAYLAVSCVLFLVARLTPYEWYSPHPCAQGRCNLLVNQYSLGNSLWFPVGGFMQQGSTIAPRALSTRCVSGV
TM3
WWFFALMMLSTYTANLAAFLTSNKWQSSIKSLQDLIEQDKVHFGSMRGGSTSLFFSESNDTDYQRAWNQMKDFNPSAFTSTNKEGVARVRKEKGGYAFLMETTSLTY
WWAFTLIIISSYTANLAAFLTVQRMDVPIESVDDLADQTAIEYGTIHGGSSMTFFQNSRYQTYQRMWNYMYSKQPSVFVKSTEEGIARVLNSN--YAFLLESTMNEY
TM4
NIERNCDLTQIGEQIGEKHYGLAVPLGSDYRTNLSVSILQLSERGELQKMKNKWWKNHNVTCDSYHEVDGDELSIIELGGVFLVLAGGVLIGVILGIFEFLWNVQNYRQRNCNLTQIGGLLDTKGYGIGMPVGSVFRDEFDLAILQLQENNRLEILKRKWWEGGKCPKEEDHRAKG--LGMENIGGIFVVLICGLIVAIFMAMLEFLWTLRHS

------------------VAVEERVTPWQAFKAELIFALKFWVRKKPMRISSSSDK--------------------------------SSSRRSSGSRRSSKEKSRS
EATEVSVCQEMVTELRSIILCQDSIHPRRRRAAVPPPRPPIPEERRPRGTATLSNGKLCGAGEPDQLAQRLAQEAALVARGCTHIRVCPECRRFQGLRARPSPARSE
KTVS----------ESLEWEKTTNSSEPE

(Figure 1‐5b cont.)
GluR‐IIB
KA1

MHGLQFLVLLALAIASGANEDTLVIKIGAIFFD-TEMKLADAFSAALEEVNAINPALKLDAIKRYVTVDDSIVLQDIS-----CDLIGSGVAAIFGPSSK-TNSDIV
MPRVSAPLVLLPAWLVMVACSPHSLRIAAILDDPMECSRGERLSITLAKNRINRAPERLGKAKVEVDIFELLRDSEYETAETMCQILPKGVVAVLGPSSSPASSSII

EVLCNMTGIPHLQFDWHPQQSNRERMNHQLTVNVAPMELFLSAAFSDILASKTFDWKSFTIAYERSSHLIRLQHILAWKQLHKAGIKMQEFERGDDYRILWKRINNA
SNICGEKEVP--HFKVAPEEFVKFQFQRFTTLNLHPSNTDISVAVAGILN--FFNCTTACLICAKAECLLNLEKLLRQFLISKDTLSVRMLDDTRDPTPLLKEIRDD

REKFVLLDCPSDILVDVINASIGYNMTGSFNHLFLTNLDTHLSGIDGFYSR-----DFTVAVAAVRIRTYVPPPVHDEIDVFDNSVDTRFSSLGSQLVYDSIVLFYN
KTATIIIHANASMSHTILLKAAELGMVSAYYTYIFTNLEFSLQRMDSLVDDRVNILGFSIFNQSHAFFQEFAQSLNQSWQENCDHVPFTGPALSSALLFDAVYAVVT

ALLEISQRPGFYIPNFSCG-RGFWQPGPRLVEQMKQITPKMVKPPFKTQRLQINADGQREDFNLEVYNPIIDRVTHIWNKEFQLVDFEKLRENSTQALKQKRLQNKE
AVQELNRSQEIGVKPLSCGSAQIWQHGTSLMNYLR-----MVELEGLTGHIEFNSKGQRSNYALKILQFTRNGFRQIG--QWHVAEGLSMDSHLYASNISDTLFN--

DFSQKPIRYTVATRVGKPYFSWREEPEGVHYEGNERFEGYAVDLIYMLAQECKFDFNFEPVRDNKYGSYDANTDEWDGIIRQLIDNNAQIGICDLTITQARRSVVDF
------TTLVVTTILENPYLMLKG--NHQEMEGNDRYEGFCVDMLKELAEILRFNYKIRLVGDGVYGVPEAN-GTWTGMVGELIARKADLAVAGLTITAEREKVIDF
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TM1
TM2
TVPFMQLGISILSYKEPPPKADIYAFLNPYNAEVWLFVMIAMMITAFALIFTGRIDQYEWDQPVENVN-REMERQNIWHLSNALWLVLGSMLNQGCDLLPRGLPMRL
SKPFMTLGISILYRVHMGRKPGYFSFLDPFSPGVWLFMLLAYLAVSCVLFLVARLTPYEWYSPHPCAQGRCNLLVNQYSLGNSLWFPVGGFMQQGSTIAPRALSTRC
TM3
LTAFWWIFALLISQTYIAKLAAFITSSKIAGDIGSLHDLVDQNKVQFGTIRGGATSVYFSESNDTDNRMAWNKMLSFKPDAFTKNNEEGVDRVKLSKGTYAFLMETT
VSGVWWAFTLIIISSYTANLAAFLTVQRMDVPIESVDDLADQTAIEYGTIHGGSSMTFFQNSRYQTYQRMWNYMYSKQPSVFVKSTEEGIARVLNSN--YAFLLEST
TM4
NLQYYVQRNCELTQIGESFGEKHYGIAVPLNADFRSNLSVGILRLSERGELFKLRNKWFNSNESTCDSNVPTIDDGQFDMDSVGGLFVVLIVGVVVGLVIGVAEFLW
MNEYYRQRNCNLTQIGGLLDTKGYGIGMPVGSVFRDEFDLAILQLQENNRLEILKRKWWEGGKCPKEEDHRAKGLG---MENIGGIFVVLICGLIVAIFMAMLEFLW

HVQR-----ISVKEKIPPMLALKAEFYFVIRFWLTRKPLHTYRQ--SRDSTSTGYSSLEQITSASSAKKKKKTRRIEK----------------------------TLRHSEATEVSVCQEMVTELRSIILCQDSIHPRRRRAAVPPPRPPIPEERRPRGTATLSNGKLCGAGEPDQLAQRLAQEAALVARGCTHIRVCPECRRFQGLRARPS
-------------------PARSEESLEWEKTTNSSEPE

(Figure 1‐5b cont.)
GluR‐IIC
KA1

-MKKELSGNSSARWPQMFGGNSREAGMWQRILLLGCMWSAFFMCRSRGQQINIGAFFYDDELELEKEFMTVVNAINGPESEQTMRFYPLIKRLKPEDGSVTMQEHAC
MPRVSAPLVLLPAWLVMVACSP-------HSLRIAAILDDPMECS-RGERLSI---------TLAKNRINRAPERLG-KAKVEVDIFELLR-----DSEYETAETMC

DLIDNGVAAIFGPSSK-AASDIVALVCNSTGIPHIEFDISDEGIQAEKPNHQMTLNLYPAQAILSKAYADIVQNFGWRKFTIVYDADDARAAARLQDLLQLREVHND
QILPKGVVAVLGPSSSPASSSIISNICGEKEVP--HFKVAPEEFVKFQFQRFTTLNLHPSNTDISVAVAGILNFFNCTTACLICAK--AECLLNLEKLLRQFLISKD

VVRVRKFHKDDDFRVMWKSIRGER--RVVLDCEPNMLVELLNSSTEFGLTGQYNHIFLTNLETYTDHLEELAADNETFAVNITAARLLVNPDPPPYSLPYGYVTQRD
TLSVRMLDDTRDPTPLLKEIRDDKTATIIIHANASMSHTILLKAAELGMVSAYYTYIFTNLEFSLQRMDSLVDDRVNILGFSIFNQSHAFFQEFAQSLNQSWQENCD

NIVYESSDPPRTLIHDLIHDALQLFAQSWRNASFFYPDRMVVPRITCDFAASGGRTWAMGRYLARLMKGTSGVNNTNFRTSILQFDEDGQRITFNIEVYDPLDGIGI
HVPFTGPALSSALLFDAVYAVVTAVQELNR------SQEIGVKPLSCGSAQIWQHGTSLMNYLR-MVELEGLTGHIEFNSKGQRSNYALKILQFTRNGFRQIGQWHV

AIWDPRGQITQLNVDVKAQKKMIYRVATRIGPPYFSYNETARELNLTGNALYQGYAVDLIDAIARHVGFEYVFVPVADQQYGKLDKETKQWNGIIGEIINNDAHMGI
AEGLSMDSHLYASNISDTLFNTTLVVTTILENPYLMLKGNHQEME--GNDRYEGFCVDMLKELAEILRFNYKIRLVGDGVYG-VPEANGTWTGMVGELIARKADLAV
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TM1
TM2
CDLTITQARKTAVDFTVPFMQLGVSILAYKSPHVEKTLDAYLAPFGGEVWIWILISVFVMTFLKTIVARISKMDWENPHPCNR-DPEVLENQWRIHNTGWLTVASIM
AGLTITAEREKVIDFSKPFMTLGISILYRVHMGRKPGYFSFLDPFSPGVWLFMLLAYLAVSCVLFLVARLTPYEWYSPHPCAQGRCNLLVNQYSLGNSLWFPVGGFM
TM3
TAGCDILPRSPQVRMFEATWWIFAIIIANSYTANLAAFLTSSKMEGSIANLKDLSAQKKVKFGTIYGGSTYNLLADSNETVYRLAFNLMNNDDPSAYTKDNLEGVDR
QQGSTIAPRALSTRCVSGVWWAFTLIIISSYTANLAAFLTVQRMDVPIESVDDLADQTAIEYGTIHGGSSMTFFQNSRYQTYQRMWNYMYSKQPSVFVKSTEEGIAR

VRKNRGDYMFLMETTTLEYHREQNCDLRSVGEKFGEKHYAIAVPFGAEYRSNLSVAILKLSERGELYDLKQKWWKNPNASCFEEPDPDATPDMTFEELRGIFYTLYA
VLN--SNYAFLLESTMNEYYRQRNCNLTQIGGLLDTKGYGIGMPVGSVFRDEFDLAILQLQENNRLEILKRKWWEG--GKCPKEED-HRAKGLGMENIGGIFVVLIC
TM4
GILIAFLIGITEFLVYVQQVALEERLTFKDAFKKEIRFVLC---VWNNRKPIVAGTPISSVRTTPRRSLDKSLDR-------------TPKSSRRVVIGRSSEEMRE
GLIVAIFMAMLEFLWTLRHSEATEVSVCQEMVTELRSIILCQDSIHPRRRRAAVPPPRPPIPEERRPRGTATLSNGKLCGAGEPDQLAQRLAQEAALVARGCTHIRV
MAQGSGSSSGSNNAGRGEKEARV-----------CPECRRFQGLRARPSPARSEESLEWEKTTNSSEPE

(Figure 1‐5b cont.)
GluR‐IID
KA1

MHFCWISLIILSLSRVQAQFYGGNAYEASSGQSIRLGLITDDATDRIR------QTFEHAISVVNNELG-VPLVGETEQVAYGNSVQAFAQLCRLMQSGVGAVFGPA
---------MPRVSAPLVLLPAWLVMVACSPHSLRIAAILDDPMECSRGERLSITLAKNRINRAPERLGKAKVEVDIFELLRDSEYETAETMCQILPKGVVAVLGPS

ARHTASHLLN-ACDSKDIPFIYPHLSWGS-----NPDGFNLHPSPEDIANALYDIVNQFEWSRFIFCYESAEYLKILDHLMTRYGIKGPVIKVMRYDLNLNGNYKSV
SSPASSSIISNICGEKEVPHFKVAPEEFVKFQFQRFTTLNLHPSNTDISVAVAGILNFFNCTTACLICAKAECLLNLEKLLRQFLISKDTLSVRMLDDTRDP--TPL

LRRIRKSEDSRIVVVGSTTGVAELLRQAQQVGIMNEDYTYIIGNLNLHTFDLEEYKYSEANITGIRMFSPDQEEVRDLMEKLHQELGE---SEPVNSGSTFITMEMA
LKEIRDDKTATIIIHANASMSHTILLKAAELGMVSAYYTYIFTNLEFSLQRMDSLVDDRVNILGFSIFNQSHAFFQEFAQSLNQSWQENCDHVPFTGPALSSALLFD

LTYDAVRVIAETTKHLPYQPQMLNCSERHDNVQPDGSTFRNYMRSLEIKEKTITGRIYFEGN-VRKGFTFDVIELQTSGLVKVGTWEEGKDFEFQRPPQAVNFNDID
AVYAVVTAVQELNRSQEIGVKPLSCGS--AQIWQHGTSLMNYLRMVELEG--LTGHIEFNSKGQRSNYALKILQFTRNGFRQIGQWHVAEGLSMDSHLYASNISDT-

DGSLVNKTFIVLISVATKPYASLVESIDTLIGNNQFQGYGVDLIKELADKLGFNFTFRDGGNDYGSFNKTTNSTSGMLKEIVEGRADLAITDLTITSEREEVIDFSI
----LFNTTLVVTTILENPYLMLKGNHQEMEGNDRYEGFCVDMLKELAEILRFNYKIRLVGDGVYGVPEANGTWTGMVGELIARKADLAVAGLTITAEREKVIDFSK
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TM1
TM2
PFMNLGIAILYVKPQKAPPALFSFMDPFSSEVWLYLGIAYLGVSLCFFIIGRLSPIEWDNPYPCIE-EPEELENQFTINNSLWFTTGALLQQGSEIAPKALSTRTIS
PFMTLGISILYRVHMGRKPGYFSFLDPFSPGVWLFMLLAYLAVSCVLFLVARLTPYEWYSPHPCAQGRCNLLVNQYSLGNSLWFPVGGFMQQGSTIAPRALSTRCVS
TM3
AIWWFFTLIMVSSYTANLAAFLTIENPTSPINSVKDLADNKDDVQYGAKRTGSTRNFFSTSEEPIYIKMNEYLN-AHPEMLMENNQQGVDKVKSGTKYAFLMESTSI
GVWWAFTLIIISSYTANLAAFLTVQRMDVPIESVDDLADQT-AIEYGTIHGGSSMTFFQNSRYQTYQRMWNYMYSKQPSVFVKSTEEGIARVLN-SNYAFLLESTMN
TM4
EFNTVRECNLTKVGDPLDEKGYGIAMVKNWPYRDKFNKALLELQEQGVLARLKNKWWNEVGAGVCSAKSDDDGPSELGVDNLSGIYVVLVIGSIISIIISILCWCYF
EYYRQRNCNLTQIGGLLDTKGYGIGMPVGSVFRDEFDLAILQLQENNRLEILKRKWWEGG----KCPKEEDHRAKGLGMENIGGIFVVLICGLIVAIFMAMLEFLWT

VYKKAKNYEVPFCDALAEEFRIVIRFSENERPLKSAQSIYS-------------------------------------------------------------RSRNS
LR-HSEATEVSVCQEMVTELRSIILCQDSIHPRRRRAAVPPPRPPIPEERRPRGTATLSNGKLCGAGEPDQLAQRLAQEAALVARGCTHIRVCPECRRFQGLRARPS
-SQSIESLKTDSEENMPVED
PARSEESLEWEKTTNSSEPE

(Figure 1‐5b cont.)
GluR‐IIE
KA1

MFFNHFVILWSLFSIHISVNWAQYENFGGYDNYQSLESVPIGLLTDQNTEQMNIVFDH-AIDVANQEVGTSLTSLKEEVNYG-DAYQSYGKLCRMLETGIAGVFGPS
---------MPRVSAPLVLLPAWLVMVACSPHSLRIAAILDDPMECSRGERLSITLAKNRINRAPERLGKAKVEVDIFELLRDSEYETAETMCQILPKGVVAVLGPS

SRHTAVHLMS-ICDAMDIPHIYS-------YMSENAEGFNLHPHPADLAKALYSLITEFNWTRFIFLYESAEYLNILNELTTMLGKSGTVITVLRYDMQLNGNYKQV
SSPASSSIISNICGEKEVPHFKVAPEEFVKFQFQRFTTLNLHPSNTDISVAVAGILNFFNCTTACLICAKAECLLNLEKLLRQFLISKDTLSVRMLDDTRDP--TPL

LRRVRKSVDNRIVVVGSSETMPEFLNQAQQVGIINEDYKYIIGNLDFHSFDLEEYKYSEANITGLRLFSPEKMAVKELLMKLGYPTDQDEFRNGSCPITVEMALTYD
LKEIRDDKTATIIIHANASMSHTILLKAAELGMVSAYYTYIFTNLEFSLQRMDSLVDDRVNILGFSIFNQSHAFFQEFAQSLNQSWQENCDHVPFTGPALSSALLFD

AVQLFAQTLKNLPFKPMP--QNCSQRTESVRDDGSSFKNYMRTLRLTDRLLTGPIYFEGN-VRKGYHLDVIELQPSGIVKVGTWDEDRQYRPQRLAPTTAQFDSVDN
AVYAVVTAVQELNRSQEIGVKPLSCGSAQIWQHGTSLMNYLRMVELEG--LTGHIEFNSKGQRSNYALKILQFTRNGFRQIGQWH-----VAEGLSMDSHLYASNIS

SLANKTFIILLSVPNKPYAQLVETYKQLEGNSQYEGYGVDLIKELADKLGFNFTFVNGGNDYGSYNKSTNESTGMLREIMTGRADLAITDLTITSEREQALDFTIPF
DTLFNTTLVVTTILENPYLMLKGNHQEMEGNDRYEGFCVDMLKELAEILRFNYKIRLVGDGVYGVPEANGTWTGMVGELIARKADLAVAGLTITAEREKVIDFSKPF

43

TM1
TM2
MNLGIAILYLKPQKATPELFTFMDPFSEEVWWFLGFSFLGVSLSFFILGRLSPSEWDNPYPCIE-EPEELENQFTLGNSIWFTTGALLQQGSEIGPKALSTRTVASF
MTLGISILYRVHMGRKPGYFSFLDPFSPGVWLFMLLAYLAVSCVLFLVARLTPYEWYSPHPCAQGRCNLLVNQYSLGNSLWFPVGGFMQQGSTIAPRALSTRCVSGV
TM3
WWFFTLIVVSSYTANLAAFLTIEKPQSLINSVDDLADNKDGVVYGAKKTGSTRNFFMTSAEERYKKMNKFMS-ENPQYLTEDNMEGVNRVKTNTHYAFLMESTSIEY
WWAFTLIIISSYTANLAAFLTVQRMDVPIESVDDLADQT-AIEYGTIHGGSSMTFFQNSRYQTYQRMWNYMYSKQPSVFVKSTEEGIARVLN-SNYAFLLESTMNEY
TM4
NTKRECNLKKIGDALDEKGYGIAMRKDWPHRGKFNNALLELQEQGVLEKMKNKWWNEVGTGICATKEDAPDATPLDMNNLEGVFFVLLVGSCCALLYGIISWVLFVM
YRQRNCNLTQIGGLLDTKGYGIGMPVGSVFRDEFDLAILQLQENNRLEILKRKWWEGG----KCPKEEDHRAKGLGMENIGGIFVVLICGLIVAIFMAML-EFLWTL

KKAHHYRVPLRDALKEEFQFVIDFNNYVRVLKNSASIYSR-----------------------SRQSSMSVASVAQESQ---------------------------RHSEATEVSVCQEMVTELRSIILCQDSIHPRRRRAAVPPPRPPIPEERRPRGTATLSNGKLCGAGEPDQLAQRLAQEAALVARGCTHIRVCPECRRFQGLRARPSPA
-----------------RSEESLEWEKTTNSSEPE

(Figure 1‐5b cont.)
GluR‐IIA MRLCPVVIYAFIIIIGFLEGIIALGGDDRNEITVGAIFYENEKEIELSFDQAFREVNNMKFSELRFVTIKRYMPTNDSFLLQQITCELISNGVAAIFGPSSK-AASD
KA2
---MPAELLLLLIVAFASPSCQVLSSLRMAAILDDQTVCGRGERLALALAREQINGIIEVPAKARVEVDIFELQRDSQYETTDTMCQILPKGVVSVLGPSSSPASAS

IVAQIANATGIPHIEYDLKLEATRQEQLNHQMSINVAPSLSVLSRAYFEIIKSNYEWRTFTLIYETPEGLARLQDLMNIQALNSDYVKLRNLADYADDYRILWKETD
TVSHICGEKEIPHIKVGP--EETPRLQYLRFASVSLYPSNEDVSLAVSRILKS-FNYPSASLICAKAECLLRLEELVRGFLISKETLSVRMLDDSRDPTPLLKEIRD

ETFHEQRIILDCEPKTLKELLKVSIDFKLQGPFRNWFLTHLDTHNSGLRDIYNED-----FKANITSVRLKVVDANPFERKKTRLTKVDQILGNQTMLPILIYDAVV
D--KVSTIIIDANASISHLILRKASELGMTSAFYKYILTTMDFPILHLDGIVEDSSNILGFSMFNTSHPFYPEFVRSLNMSWRENCEASTYLG-PALSAALMFDAVH

LFASSARNVIAAMQPFHPPNRHCGSSSPWMLGAFIVNEMKTISEDDVEPHFKTENMKLDEYGQRIHFNLEIYKPTVN--EPMMVWTPDNGIKKRLLNLELESAGTTQ
VVVSAVR-ELNRSQEIGVKPLACTSANIWPHGTSLMNYLRMVEYDGLT-----GRVEFNSKGQRTNYTLRILEKSRQGHREIGVWYSN-----RTLAMNATTLDINL

DFSEQRKVYTVVTHYEEPYFMMKEDHENFRGREKYEGYAVDLISKLSELMEFDYEFMIVNGNGKYNPETK-QWDGIIRKLIDHHAQIGVCDLTITQMRRSVVDFTVP
SQTLANKTLVVTTILENPYVMRRPNFQALSGNERFEGFCVDMLRELAELLRFRYRLRLVEDGLYGAPEPNGSWTGMVGELINRKADLAVAAFTITAEREKVIDFSKP
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TM1
TM2
FMQLGISILHYKSPPEPKNQFAFLEPFAVEVWIYMIFAQLIMTLAFVFIARLSYREWLPPNPAIQD-PDELENIWNVNNSTWLMVGSIMQQGCDILPRGPHMRILTG
FMTLGISILYRVHMGRKPGYFSFLDPFSPAVWLFMLLAYLAVSCVLFLAARLSPYEWYNPHPCLRARPHILENQYTLGNSLWFPVGGFMQQGSEIMPRALSTRCVSG
TM3
MWWFFALMMLSTYTANLAAFLTSNKWQSSIKSLQDLIEQDKVHFGSMRGGSTSLFFSESNDTDYQRAWNQMKDFNPSAFTSTNKEGVARVRKEKGGYAFLMETTSLT
VWWAFTLIIISSYTANLAAFLTVQRMEVPVESADDLADQTNIEYGTIHAGSTMTFFQNSRYQTYQRMWNYMQSKQPSVFVKSTEEGIARVLNSR--YAFLLESTMNE
TM4
YNIERNCDLTQIGEQIGEKHYGLAVPLGSDYRTNLSVSILQLSERGELQKMKNKWWKNHNVTCDSYHEVDGDELSIIELGGVFLVLAGGVLIGVILGIFEFLWNVQN
YHRRLNCNLTQIGGLLDTKGYGIGMPLGSPFRDEITLAILQLQENNRLEILKRKWWEGGRCPKEEDHRAKG--LGMENIGGIFIVLICGLIIAVFVAVMEFIWSTRR

VAVEERVTPWQAFKAELIFALKFWVRKKP--------------------------------------------------------------------MRISSSSDKS
SAESEEVSVCQEMLQELRHAVSCRKTSRSRRRRRPGGPSRALLSLRAVREMRLSNGKLYSAGAGGDAGSAHGGPQRLLDDPGPPSGARPAAPTPCTHVRVCQECRRI
SSRRSSGSRRSSKEKSRSKTVS------------------QALRASGAGAPPRGLGVPAEATSPPRPRPGPAGPRELAEHE

(Figure 1‐5b cont.)
GluR‐IIB
KA2

MHGLQFLVLLALAIASGANEDTLVIKIGAIFFDTEMKLAD---AFSAALEEVN---AINPALKLDAIKRYVTVDDSIVLQDISCDLIGSGVAAIFGPSSK-TNSDIV
-MPAELLLLLIVAFASPSCQVLSSLRMAAILDDQTVCGRGERLALALAREQINGIIEVPAKARVEVDIFELQRDSQYETTDTMCQILPKGVVSVLGPSSSPASASTV

EVLCNMTGIPHLQFDWHPQQSNRERMNHQLTVNVAPMELFLSAAFSDILASKTFDWKSFTIAYERSSHLIRLQHILAWKQLHKAGIKMQEFERGDDYRILWKRINNA
SHICGEKEIPHIKVG--PEETPRLQYLRFASVSLYPSNEDVSLAVSRILKS--FNYPSASLICAKAECLLRLEELVRGFLISKETLSVRMLDDSRDPTPLLKEIRDD

REKFVLLDCPSDILVDVINASIGYNMTGSFNHLFLTNLDT---HLSGIDGFYSRDFTVAVAAVRIRTYVPPPVHDEIDVFDNSVDTRFS--SLGSQLVYDSIVLFYN
KVSTIIIDANASISHLILRKASELGMTSAFYKYILTTMDFPILHLDGIVEDSSNILGFSMFNTSHPFYPEFVRSLNMSWRENCEASTYLGPALSAALMFDAVHVVVS

ALLEISQRPGFYIPNFSCGRG-FWQPGPRLVEQMKQITPKMVKPPFKTQRLQINADGQREDFNLEVYNPIIDRVTHIWNKEFQLVDFEKLRENSTQALKQKRLQNKE
AVRELNRSQEIGVKPLACTSANIWPHGTSLMNYLR-----MVEYDGLTGRVEFNSKGQRTNYTLRILEKSRQGHREIG----------VWYSNRTLAMNATTLDINL

DFSQKPIRYTVATRVGKPYFSWREEPEGVHYEGNERFEGYAVDLIYMLAQECKFDFNFEPVRDNKYGSYDANTDEWDGIIRQLIDNNAQIGICDLTITQARRSVVDF
SQTLANKTLVVTTILENPYVMRR--PNFQALSGNERFEGFCVDMLRELAELLRFRYRLRLVEDGLYGAPEPN-GSWTGMVGELINRKADLAVAAFTITAEREKVIDF
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TM1
TM2
TVPFMQLGISILSYKEPPPKADIYAFLNPYNAEVWLFVMIAMMITAFALIFTGRIDQYEWDQPVENVN-REMERQNIWHLSNALWLVLGSMLNQGCDLLPRGLPMRL
SKPFMTLGISILYRVHMGRKPGYFSFLDPFSPAVWLFMLLAYLAVSCVLFLAARLSPYEWYNPHPCLRARPHILENQYTLGNSLWFPVGGFMQQGSEIMPRALSTRC
TM3
LTAFWWIFALLISQTYIAKLAAFITSSKIAGDIGSLHDLVDQNKVQFGTIRGGATSVYFSESNDTDNRMAWNKMLSFKPDAFTKNNEEGVDRVKLSKGTYAFLMETT
VSGVWWAFTLIIISSYTANLAAFLTVQRMEVPVESADDLADQTNIEYGTIHAGSTMTFFQNSRYQTYQRMWNYMQSKQPSVFVKSTEEGIARVLNSR--YAFLLEST
TM4
NLQYYVQRNCELTQIGESFGEKHYGIAVPLNADFRSNLSVGILRLSERGELFKLRNKWFNSNESTCDSNVPTIDDGQFDMDSVGGLFVVLIVGVVVGLVIGVAEFLW
MNEYHRRLNCNLTQIGGLLDTKGYGIGMPLGSPFRDEITLAILQLQENNRLEILKRKWWEGGRCPKEEDHRAKGLG---MENIGGIFIVLICGLIIAVFVAVMEFIW

HVQRISVKEKIPPMLALKAEFYFVIRFWLTRKP---------------LHTYRQSRDSTSTGYSS---------------------------LEQITSASSAKKKKK
STRRSAESEEVSVCQEMLQELRHAVSCRKTSRSRRRRRPGGPSRALLSLRAVREMRLSNGKLYSAGAGGDAGSAHGGPQRLLDDPGPPSGARPAAPTPCTHVRVCQE
TRRIEK--------------------------------------CRRIQALRASGAGAPPRGLGVPAEATSPPRPRPGPAGPRELAEHE

(Figure 1‐5b cont.)
GluR‐IIC
KA2

MKKELSGNSSARWPQMFGGNSREAGMWQRILLLGCMWSAFFMCRSRGQQINIGAFFYDDELELEKEFMTVVNAINGPESEQTMRFYPLIKRLKPEDGSVTMQEHACD
-------MPAELLLLLIVAFASPSCQVLSSLRMAAILDDQTVCG-RGERL---------ALALAREQINGIIEVP-AKARVEVDIFELQR-----DSQYETTDTMCQ

LIDNGVAAIFGPSSK-AASDIVALVCNSTGIPHIEFDISDEGIQAEKPNHQMTLNLYPAQAILSKAYADIVQNFGWRKFTIVYDADDARAAARLQDLLQLREVHNDV
ILPKGVVSVLGPSSSPASASTVSHICGEKEIPHIKVGP--EETPRLQYLRFASVSLYPSNEDVSLAVSRILKSFNYPSASLICAK--AECLLRLEELVRGFLISKET

VRVRKFHKDDDFRVMWKSIRGERR--VVLDCEPNMLVELLNSSTEFGLTGQYNHIFLTNLETYTDHLEELAADNETFAVNITAARLLVNPDPPPYSLPYGYVTQRDN
LSVRMLDDSRDPTPLLKEIRDDKVSTIIIDANASISHLILRKASELGMTSAFYKYILTTMDFPILHLDGIVED----SSNILGFSMFNTSHPFYPEFVRSLNMSWRE

IVYESSDPPRTLIHDLIHDALQLFAQSWRNASFFYPDRMVVPRITCDFAASGGRTWAMGRYLARLMKGTSGVNNTNFRTSILQFDEDGQRITFNIEVYDPLDG--IG
NCEASTYLGPALSAALMFDAVHVVVSAVR--ELNRSQEIGVKPLACTSAN----IWPHGTSLMNYLR----MVEYDGLTGRVEFNSKGQRTNYTLRILEKSRQGHRE

IAIWDPRGQITQLNVDVKAQKKMIYRVATRIGPPYFSYNETARELN---LTGNALYQGYAVDLIDAIARHVGFEYVFVPVADQQYGKLDKETKQWNGIIGEIINNDA
IGVWYSNRTLAMNATTLDINLSQTLANKTLVVTTILENPYVMRRPNFQALSGNERFEGFCVDMLRELAELLRFRYRLRLVEDGLYGAPEPN-GSWTGMVGELINRKA
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TM1
TM2
HMGICDLTITQARKTAVDFTVPFMQLGVSILAYKSPHVEKTLDAYLAPFGGEVWIWILISVFVMTFLKTIVARISKMDWENPHPCNRD-PEVLENQWRIHNTGWLTV
DLAVAAFTITAEREKVIDFSKPFMTLGISILYRVHMGRKPGYFSFLDPFSPAVWLFMLLAYLAVSCVLFLAARLSPYEWYNPHPCLRARPHILENQYTLGNSLWFPV
TM3
ASIMTAGCDILPRSPQVRMFEATWWIFAIIIANSYTANLAAFLTSSKMEGSIANLKDLSAQKKVKFGTIYGGSTYNLLADSNETVYRLAFNLMNNDDPSAYTKDNLE
GGFMQQGSEIMPRALSTRCVSGVWWAFTLIIISSYTANLAAFLTVQRMEVPVESADDLADQTNIEYGTIHAGSTMTFFQNSRYQTYQRMWNYMQSKQPSVFVKSTEE

GVDRVRKNRGDYMFLMETTTLEYHREQNCDLRSVGEKFGEKHYAIAVPFGAEYRSNLSVAILKLSERGELYDLKQKWWKNPNASCFEEPDPDATPDMTFEELRGIFY
GIARVLNSR--YAFLLESTMNEYHRRLNCNLTQIGGLLDTKGYGIGMPLGSPFRDEITLAILQLQENNRLEILKRKWWEG--GRCPKEED-HRAKGLGMENIGGIFI
TM4
TLYAGILIAFLIGITEFLVYVQQVALEERLTFKDAFKKEIRFVLCVWNNRKP-------------------------------IVAGTPISSVRTTPRRSLDKS--VLICGLIIAVFVAVMEFIWSTRRSAESEEVSVCQEMLQELRHAVSCRKTSRSRRRRRPGGPSRALLSLRAVREMRLSNGKLYSAGAGGDAGSAHGGPQRLLDDPGPP
LDRTPKSSRRVVIGRSSEEMREMAQGSGSSSGSNNAGRGEKEARV------------------SGARPAAPTPCTHVRVCQECRRIQALRASGAGAPPRGLGVPAEATSPPRPRPGPAGPRELAEHE

(Figure 1‐5b cont.)
GluR‐IID MHFCWISLIILSLSRVQAQFYGGNAYEASSGQSIRLGLITDDATDRIRQTFEHAISVVNNELGVPLVGETEQVAYGNSVQAFAQLCRLMQSGVGAVFGPAAR-HTAS
MPAELLLLLIVAFASPSCQVLSSLRMAAILDDQTVCGRGERLALALAREQINGIIEVPAKAR---VEVDIFELQRDSQYETTDTMCQILPKGVVSVLGPSSSPASAS
KA2
HLLNACDSKDIPFIYPHLSWGS-----NPDGFNLHPSPEDIANALYDIVNQFEWSRFIFCYESAEYLKILDHLMTRYGIKGPVIKVMRYDLNLNGNYKSVLRRIRKS
TVSHICGEKEIPHIKVGPEETPRLQYLRFASVSLYPSNEDVSLAVSRILKSFNYPSASLICAKAECLLRLEELVRGFLISKETLSVRMLDDSRDP--TPLLKEIRDD

EDSRIVVVGSTTGVAELLRQAQQVGIMNEDYTYIIGNLNLHTFDLEEYKYSEANITGIRMFSPDQEEVRDLMEKLHQELGESEPVNSGSTFITMEMALTYDAVRVIA
KVSTIIIDANASISHLILRKASELGMTSAFYKYILTTMDFPILHLDGIVEDSSNILGFSMFNTSHPFYPEFVRSLNMSWREN-CEASTYLGPALSAALMFDAVHVVV

ETTKHLPYQP--QMLNCSERHDNVQPDGSTFRNYMRSLEIKEKTITGRIYFEGN-VRKGFTFDVIELQTSGLVKVGTWEEGKDFEFQRPPQAVNFNDIDDGSLVNKT
SAVRELNRSQEIGVKPLACTSANIWPHGTSLMNYLRMVEYDG--LTGRVEFNSKGQRTNYTLRILEKSRQG HREIGVWYSNRTLAMNATTLDINLSQT----LANK

FIVLISVATKPYASLVESIDTLIGNNQFQGYGVDLIKELADKLGFNFTFRDGGNDYGSFNKTTNSTSGMLKEIVEGRADLAITDLTITSEREEVIDFSIPFMNLGIA
TLVVTTILENPYVMRRPNFQALSGNERFEGFCVDMLRELAELLRFRYRLRLVEDGLYGAPEPNGSWTGMVGELINRKADLAVAAFTITAEREKVIDFSKPFMTLGIS
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TM1
TM2
ILYVKPQKAPPALFSFMDPFSSEVWLYLGIAYLGVSLCFFIIGRLSPIEWDNPYPCIEE-PEELENQFTINNSLWFTTGALLQQGSEIAPKALSTRTISAIWWFFTL
ILYRVHMGRKPGYFSFLDPFSPAVWLFMLLAYLAVSCVLFLAARLSPYEWYNPHPCLRARPHILENQYTLGNSLWFPVGGFMQQGSEIMPRALSTRCVSGVWWAFTL
TM3
IMVSSYTANLAAFLTIENPTSPINSVKDLADNKDDVQYGAKRTGSTRNFFSTSEEPIYIKMNEYLN-AHPEMLMENNQQGVDKVKSGTKYAFLMESTSIEFNTVREC
IIISSYTANLAAFLTVQRMEVPVESADDLADQTN-IEYGTIHAGSTMTFFQNSRYQTYQRMWNYMQSKQPSVFVKSTEEGIARVLN-SRYAFLLESTMNEYHRRLNC
TM4
NLTKVGDPLDEKGYGIAMVKNWPYRDKFNKALLELQEQGVLARLKNKWWNEVGAGVCSAKSDDDGPSELGVDNLSGIYVVLVIGSIISIIISILCWCYFVYKKAKNY
NLTQIGGLLDTKGYGIGMPLGSPFRDEITLAILQLQENNRLEILKRKWWEGG----RCPKEEDHRAKGLGMENIGGIFIVLICGLIIAVFVAVMEFIWSTRRSAESE

EVPFCDALAEEFRIVIRFSENER------------------------------------------------------------PLKSAQSIYSRSRNSSQSIESLKT
EVSVCQEMLQELRHAVSCRKTSRSRRRRRPGGPSRALLSLRAVREMRLSNGKLYSAGAGGDAGSAHGGPQRLLDDPGPPSGARPAAPTPCTHVRVCQECRRIQALRA
DSE------ENMPVED-------------------SGAGAPPRGLGVPAEATSPPRPRPGPAGPRELAEHE

(Figure 1‐5b cont.)
GluR‐IIE
KA2

MFFNHFVILWSLFSIHISVNWAQYENFGGYDNYQSLESVPIGLLTDQNTEQMNIVFDHAIDVANQEVGTSLTSLKEEVNYGDAYQSYGKLCRMLETGIAGVFGPSSR
-MPAELLLLLIVAFASPSCQVLSSLRMAAILDDQTVCGRGERLALALAREQINGIIEVPAKAR---VEVDIFELQRDS----QYETTDTMCQILPKGVVSVLGPSSS

-HTAVHLMSICDAMDIPHIYSYMSEN-------AEGFNLHPHPADLAKALYSLITEFNWTRFIFLYESAEYLNILNELTTMLGKSGTVITVLRYDMQLNGNYKQVLR
PASASTVSHICGEKEIPHIKVGPEETPRLQYLRFASVSLYPSNEDVSLAVSRILKSFNYPSASLICAKAECLLRLEELVRGFLISKETLSVRMLDDSRDP--TPLLK

RVRKSVDNRIVVVGSSETMPEFLNQAQQVGIINEDYKYIIGNLDFHSFDLEEYKYSEANITGLRLFSPEKMAVKELLMKLGYPTDQDEFRNGSCPITVEMALTYDAV
EIRDDKVSTIIIDANASISHLILRKASELGMTSAFYKYILTTMDFPILHLDGIVEDSSNILGFSMFNTSHPFYPEFVRSLNMSWRENCEASTYLGPALSAALMFDAV

QLFAQTLKNLPFKPMP--QNCSQRTESVRDDGSSFKNYMRTLRLTDRLLTGPIYFEGN-VRKGYHLDVIELQPSGIVKVGTWDEDRQYRPQRLAPTTAQFDSVDNSL
HVVVSAVRELNRSQEIGVKPLACTSANIWPHGTSLMNYLRMVEYDG--LTGRVEFNSKGQRTNYTLRILEKSRQGHREIGVWYSN---RTLAMNATTLDIN-LSQTL

ANKTFIILLSVPNKPYAQLVETYKQLEGNSQYEGYGVDLIKELADKLGFNFTFVNGGNDYGSYNKSTNESTGMLREIMTGRADLAITDLTITSEREQALDFTIPFMN
ANKTLVVTTILEN-PYVMRRPNFQALSGNERFEGFCVDMLRELAELLRFRYRLRLVEDGLYGAPEPNGSWTGMVGELINRKADLAVAAFTITAEREKVIDFSKPFMT
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TM1
TM2
LGIAILYLKPQKATPELFTFMDPFSEEVWWFLGFSFLGVSLSFFILGRLSPSEWDNPYPCIEE-PEELENQFTLGNSIWFTTGALLQQGSEIGPKALSTRTVASFWW
LGISILYRVHMGRKPGYFSFLDPFSPAVWLFMLLAYLAVSCVLFLAARLSPYEWYNPHPCLRARPHILENQYTLGNSLWFPVGGFMQQGSEIMPRALSTRCVSGVWW
TM3
FFTLIVVSSYTANLAAFLTIEKPQSLINSVDDLADNKDGVVYGAKKTGSTRNFFMTSAEERYKKMNKFMS-ENPQYLTEDNMEGVNRVKTNTHYAFLMESTSIEYNT
AFTLIIISSYTANLAAFLTVQRMEVPVESADDLADQTN-IEYGTIHAGSTMTFFQNSRYQTYQRMWNYMQSKQPSVFVKSTEEGIARVLN-SRYAFLLESTMNEYHR
TM4
KRECNLKKIGDALDEKGYGIAMRKDWPHRGKFNNALLELQEQGVLEKMKNKWWNEVGTGICATKEDAPDATPLDMNNLEGVFFVLLVGSCCALLYGIISWVLFVMKK
RLNCNLTQIGGLLDTKGYGIGMPLGSPFRDEITLAILQLQENNRLEILKRKWWEGG----RCPKEEDHRAKGLGMENIGGIFIVLICGLIIAVFVAVMEFIWSTRRS

AHHYRVPLRDALKEEFQFVIDFNNYVRVLKN----------------------SASIYSR----------------------------SRQSSMSVASVAQESQ--AESEEVSVCQEMLQELRHAVSCRKTSRSRRRRRPGGPSRALLSLRAVREMRLSNGKLYSAGAGGDAGSAHGGPQRLLDDPGPPSGARPAAPTPCTHVRVCQECRRIQ
---------------------------------------ALRASGAGAPPRGLGVPAEATSPPRPRPGPAGPRELAEHE

Subunit
name

Protein ID

Gene ID

Subunit
name

GluR‐IIA

NP 523484

33788

CG 3814

GluR‐IIB

NP 523485

33789

CG 33513

GluR‐IIC
(GluRIII)
GluR‐IID
(=kaiRIA)
GluR‐IIE

NP 608557
NP 722670

33275

CG 2902

NP 651982

44483

NP 001036733
NP 651941
NP 726648
NP 726649

CG 11155
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CG 9935
Clumsy
(=CG 8681)
CG 5621

NP 651931
NP 001036250
NP 001036251
NP 523610
NP 001036373
NP 650927
NP 001036735

Gene ID

Subunit
name

Protein ID

Gene ID

36418

CG 14586

NP 649013

39983

31107

CG 14585

NP 649012

39982

NP 730940

40665

CG15732

NP 572795

32189

CG 30379

NP 724626

246578

CG 6185

NP 648455

39269

318623

GluR I

NP 476855

38742

CG 15324

NP 572411

31692

43822

GluR IB

NP 524755

44484

CG 11775

NP 649833

41052

43806

CG 17274

NP 650923

42471

CG 10633

NP 647962

38616

35394

CG 31718

NP 723585

318912

CG 10101

NP 649720

40891

42476

CG 2657

NP 001097043

33157

CG 15627

NP 608863

33683

Protein ID
NP 610824
NP 725236
NP 001014716
NP 001014715
NP 001014714

CG 17275

NP 649148
NP 730452
NP 730453
NP 650924

42472

CG 17152

NP 648548

39378

CG 3822

NP 650925

42473

CG 7385

NP 649176

40198

CG 8533

CG 32704

NP 727328

31867

CG 14076

NP 649074

40065

CG 3798

NP 725237
NP 725238
NP 523722
NP 725239
NP 725241
NP 725240

36419

CG 33492
(=CG 17587)

NP 995744

2768714

40157

Table 1-1. Glutamate receptor genes in Drosophila genome. 36 different glutamate receptors genes are found in NCBI
database (National Center for Biotechnology Information).

Chapter Two
Furthering Pharmacological and Physiological Assessment of the
Glutamatergic Receptors at the Drosophila Neuromuscular Junction

INTRODUCTION
The function and pharmacology of glutamate receptors in general are of
prime interest since they are the major excitatory receptor type used within the
mammalian central nervous system (CNS). There are extensive investigations
into the pharmacology, physiology, molecular structure and regulation in
expression as well as turnover in mammalian preparations of glutamate
receptors (Dingledine et al., 1999; Hollmann and Hainemann, 1994; Lipsky and
Goldman, 2003; Mayer, 2005; Pauly et al., 2005; Seeburg, 1993; Thiagarajan et
al., 2005). Earlier studies on glutamate receptors at the neuromuscular junction
of insects and crustaceans paved the way to dissecting the functional aspects of
these receptors within vertebrates (Anderson et al. 1976; Cull-Candy and Parker,
1983; Gration et al., 1981; Jan and Jan, 1976; Patlak et al., 1979; Shinozaki and
Ishida, 1981; Shinozaki and Shibuya, 1974). Still today, invertebrate models
serve a vital role in describing regulation and developmental aspects of
glutamate receptor function (Featherstone et al., 2005; Guerrero et al., 2005;
Littleton and Ganetzky, 2000; Logsdon et al., 2006; Pawlu et al., 2004; Rasse et
al., 2005). Considering that Drosophila melanogaster is a true model organism
with a known genome and used for successful rapid induction of mutations in
various studies of development and synaptic mechanisms, it is important to
understand the pharmacological and physiological function within this model
synaptic neuromuscular preparation (Atwood et al., 1993; Betz et al. 1993; Jan
and Jan 1976; Kurdyak et al., 1994; Li et al., 2002; Li and Cooper, 2001; Pawlu
et al., 2004; Ruffner et al., 1999; Sigrist et al., 2002, 2003; Stewart et al., 1994,
1996).
The molecular sequence of the glutamate receptors on the Drosophila
skeletal muscle has been described; however, to date there are few detailed
investigations on the pharmacological profile of the intact larval Drosophila NMJ
(Chang and Kidokoro, 1996; Chang et al., 1994; Delgado et al., 1989; Schuster
et al., 1991; Zhang et al., 1999). Glutamate receptors are defined as NMDA (Nmethyl-D-aspartic acid) and non-NMDA subtypes (i.e. AMPA, kainate and δ)
based on their pharmacological sensitivity activating the receptors. The
molecular sequences of the glutamate receptors for Drosophila NMJs were
performed on the body wall muscles in larvae by isolating the skeletal muscle
and the body wall (skeletal muscles attach to the cuticle body wall). The total
mRNA was extracted from this muscle tissue and probed against an "affymetrix
Drosophila genechip". A number of Drosophila glutamate receptor subunits were
found to be present. The sequences isolated were identified by comparison to
whole larval DNA known sequences for glutamate receptors. The ones identified
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are GluRIIA, GluRIIB, GluRIIC and GluRIID. GluRIIE was later isolated when
real-time PCR was used to follow up on the amplified mRNA of the four receptor
subtypes in quantification of expression levels. The expression profile of the five
glutamate receptor subunits has been conducted in body wall muscle by in situ
hybridization for embryos and larvae (Guerrero et al., 2005; Marrus et al., 2004).
With the RT-PCR and the genomic profiling the sequence indicates that
there are 5 glutamate receptor subunits (DGluR-IIA, DGluR-IIB, DGluR-IIC,
DGluR-IID, DGluR-IIE) expressed in skeletal muscle and all of them are
ionotropic receptors. In comparing the molecular sequence of these 5 muscleexpressed glutamate receptors with vertebrates, they showed the most similarity
to the vertebrate kainate/AMPA receptor subtypes; therefore, they have been
defined as a kainate receptor subtype without pharmacological examination (Betz
et al., 1993; Guerrero et al., 2005; Marrus et al., 2004; Qin et al., 2005; Völkner
et al., 2000). However, a recent physiological and pharmacological study
demonstrates that the responses are primarily of a quisqualate subtype and not a
kainate or an AMPA subtype since the muscle is not depolarized by kainate or
AMPA at concentrations as high as 1mM (Bhatt and Cooper, 2005). In fact, it
appears that kainate might block the glutamate receptors since the excitatory
postsynaptic potential (EPSP) is reduced in the presence of kainate (on average
by 40% for 1mM and 500μM but about 20% for 100μM). The reduction in the
EPSP amplitude occurred without any significant change in resting membrane
potential; thus, kainate did not depolarize the muscle as observed for application
of glutamate or quisqualate (Bhatt and Cooper, 2005).
In addition, the procedures used to identify the molecular sequence of the
glutamate receptors at the NMJ, by homogenizing the skeletal muscle and body
wall, did not allow for assessment for potential presynaptic glutamate receptors.
In the past procedure, the CNS was removed and thus the cell bodies of the
motor neurons were not incorporated in the assay. Considering that there are
presynaptic glutamatergic receptors for neurons in the vertebrate CNS (Park et
al., 2006) and at crayfish NMJs (Schramm and Dudel, 1997), there may well be
pre-synaptic autoreceptors present at the Drosophila NMJ. Crayfish NMJs show
many similarities to the larval Drosophila NMJs (Atwood and Cooper, 1995, 1996)
which is not so surprising since they are both arthropods. However, mixed results
for the glutamatergic autoreceptors were obtained at the crayfish NMJ in that the
responses depended on the depolarized state of the nerve terminal for the
facilitatory action of exogenously applied glutamate and for the metabotropic
agonist t-ACPD (Schramm and Dudel, 1997). In addition, some preparations
showed a depression of presynaptic release while yet other preparations
exhibited excitation at the same concentration of t-ACPD. Regardless of the
response at the crayfish NMJ, there appears to be one or more types of
presynaptic, glutamatergic receptors for the crayfish preparation (Schramm and
Dudel, 1997).
The earlier observation of the rapid reduction in the EPSP by
kainate at the Drosophila NMJ is most likely due to one or both of the following
factors: (1) antagonist action on the postsynaptic glutamate receptors; (2)
reducing the number of presynaptic vesicular fusion events. It is possible both
mechanisms might occur. Direct blocking action on postsynaptic receptors is a
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possibility for kainate as many known agonists can be antagonists for subtypes
within a receptor family (Chang and Weiss, 2002; Eberle et al., 2001; Hruby et al.,
2003). This is likely as a part of the extracellular receptor domains for glutamate
receptors must be similar in order to bind glutamate. However, at the 3rd instar
Drosophila NMJ the binding of kainate does not transduce activation of the
glutamate ligand gated ion channels (Bhatt and Cooper, 2005; Dudel et al. 1992;
Heckmann and Dudel, 1997). There is also precedence for kainate, a potent
agonist for some vertebrate metabotropic receptors, to act presynaptically in
reducing evoked transmitter release via autoreceptors on the presynaptic
terminals (Chittajallu et al., 1996; Frerking et al., 2001; Kamiya and Ozawa, 1998;
McLarnon and Quastel, 1988; Park et al., 2006). Kainate is known to bind
metabotropic glutamate receptors (Zhang et al., 1999) and have a presynaptic
action in altering transmitter release from presynaptic terminals in vertebrates
(Kamiya and Ozawa, 2000; Kamiya et al., 2002; Park et al., 2006). In rats,
kainate and the kainate receptor agonist, ATPA, act presynaptically in reducing
glutamate release from primary sensory neurons (Kerchner et al., 2001).
However, in the rat neocortex, kainate receptors have been demonstrated to
have both facilitatory as well as inhibitory actions due to dose dependent effects.
The mechanism proposed for the biphasic effect is that low doses excite the
presynaptic terminal while high doses have an inhibitory effect on the
postsynaptic target (Campbell et al., 2007). Thus, depending on the type of
preparation and dosage, kainate might excite or inhibit the presynaptic terminal.
The evidence suggests a mechanism of action via kainate-sensitive
glutamatergic autoreceptors through a metabotropic action within the presynaptic
terminals or by direct action on the presynaptic voltage-gated Ca2+ channels (see
reviews Lerma, 2003 and Nicoll et al., 2000). In addition, the actions of glutamate
at newly hatched Drosophila larvae revealed presynaptic actions in enhancing
the occurrences of spontaneous events without any alteration in the amplitude of
the quantal currents (Zhang et al., 1999). The mechanisms suggested for this
phenomenon are that presynaptic autoreceptors are present which enhances
synaptic transmission. In addition, the pharmacological agonist (1S, 3S)-ACPD
for mGluR mimicked the effect of glutamate (Zhang et al., 1999). This helps to
establish that autoreceptors at this NMJ are likely in the 3rd instar and that there
maybe developmental differentiation in presynaptic receptor subtypes to account
for the depressing action of kainate in the 3rd instar.
The purpose of this study is to test for these possibilities. I have
approached this by accessing the characteristics of single quanta (i.e., peak
amplitude) and frequency of spontaneous events with intracellular measures of
miniature EPSPs (mEPSPs) from the whole muscle. I also examined further
pharmacological profiles of the Drosophila NMJ to build knowledge of this model
synaptic preparation.
METHODS
Electrophysiology and staging of flies
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All the electrophysiology and staging of larvae are routine procedures and
have been described previously. The dissection technique was previously
reported (Ball et al., 2003; Campos-Ortega and Hartenstein, 1985; Li et al.,
2002). The physiological saline is HL3 (in mM): 1.0 CaCl2 2H2O, 20 MgCl2, 70
NaCl, 5 KCl, 10NaHCO3, 5 trehalose, 115 sucrose, 5 BES (N,N-bis[2-hydroxyethyl]-2-aminoethanesulfonic acid) and adjusted to a pH of 7.2 (Stewart et al.,
1994). All experiments were performed at room temperature (20-21°C). The
recording techniques have been previously described for intracellular EPSP
measures (Dasari and Cooper, 2004; Sparks et al., 2004; Stewart et al., 1994)
and extracellular focal quantal recordings (Cooper et al., 1995a; Harrison and
Cooper, 2003). The compound amplitude of the excitatory postsynaptic potentials
(EPSP) elicited by Is and Ib motor nerve terminals in segment 3 of muscle m6
were monitored as in Kurdyak et al., (1994) and Ruffner et al., (1999). The
identified m6 muscle was used in each preparation. Only preparations with a
resting membrane potential of -50mV or greater were used and the HL3
dissection medium was completely replaced by HL3 media containing the
pharmacological compounds.
Quantal analysis
All quantal analysis of intracellular whole muscle recordings were as
described previously (Cooper et al., 1995b). The quantal analysis of measuring
spontaneous frequency and characteristics of the quantal shape are standard
approaches.
Pharmacology
In an earlier report (Bhatt and Cooper, 2005), actions of NMDA, AMPA, Lglutamate, kainate, quisqualic acid, NBQX, AP5, and DNQX, with regard to
synaptic transmission and direct effects on the muscle fibers, was examined.
This study showed that kainate reduced evoked EPSPs. The same procedures
for exchanging the bathing medium with pharmacological agents were used. The
compound trans-(±)-1-Amino-1,3-cyclopentanedicarboxylic acid monohydrate (tACPD) is a known mGluR agonist (Holscher et al., 1997) and has been shown to
have some effect on newly hatched Drosophila larvae (Zhang et al. 1999). I
examined the actions of ATPA, a known agonist of the kainate receptor in
vertebrates, and 1, 3-ACPD on synaptic responses. The ATPA, domoic acid and
the trans-(±)-1-Amino-1,3-cyclopentanedicarboxylic acid monohydrate (t-ACPD)
were obtained from Sigma
Statistical analysis
A non-parametric analysis (Wilcoxon rank sum) or a parametric Student’s
t-test were used for assigning a significance at a p<0.05 depending on the
appropriate experimental design as explained in the RESULTS section.
Sequence Comparisons
All of the glutamate receptor amino acid sequences used are annotated in
National Center for Biotechnology Information (NCBI) database. There are 36
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different genes encoding 36 different kinds of glutamate receptor subunits in
Drosophila melanogaster. Among them, five subunits consisting of postsynaptic
receptors were compared to five different kainate type glutamate receptor
subunits in Homo sapiens. Both whole protein and extracellular domain
sequences of each subunit were aligned to show the similarity and calculate the
statistical matches between two species, respectively. The bl2seq in NCBI and
Clustal W were used to align two different protein sequences. In Clustal W the
default settings were used except ITERATION to alignment and NUMERITER
were set to 3.
RESULTS
In measuring the evoked EPSPs and spontaneous quantal events a 3rd
instar larvae is filleted so that each segment is observed. By stimulating a
selected segmental nerve, only one nerve root is recruited which is important
since the muscle fibers are electrically coupled between segments. Various
identified muscles with the rather simplistic innervation profiles are shown in
Figure 2-1A. In these studies, I utilized muscle 6 (m6) because of the well
characterized innervation as depicted in Figure 2-1B (Atwood et al., 1993;
Kurdyak et al., 1994; Li et al., 2002). The synaptic properties of the Is and Ib
motor nerve terminals have been previously described (Atwood et al., 1993;
Kurdyak et al., 1994; Li et al., 2002). I obtained similar measures as earlier
reported. I did ensure to observe all three sized EPSP events (Ib, Is, and Ib+Is) in
order to subsequently monitor the compound Ib+Is EPSP. The resting membrane
potential was also monitored and only preparations which did not appear
damaged or with a resting membrane potential more negative than -50mV, in
normal physiological saline, were used for assessing the effects of various
pharmacological agents.
Application of a saline containing kainate (1mM) rapidly reduces the EPSP
amplitude and the effect can be partially reversed by extensive exchanging the
bathing media back to normal saline (Figure 2-2A). The extant in the reduction of
the EPSP amplitude is dose-dependent, with an almost 50% reduction at 1mM
(Figure 2-2B). All three concentrations produced a significant reduction in the
EPSP amplitudes (n=6 for each concentration; p<0.05 Wilcoxon rank sum nonparametric). There is no significant effect on the resting membrane potential on
m6 for any of the three concentrations tested (Figure 2-2C). However when
considering sham control experiments of exchanging the bathing medium with
saline and providing the same time period in which EPSP measure were made
there is run down in the EPSP amplitude by 13.5% (Figure 2-2D). The individual
values are shown next to the mean value. The sham procedures produced a
significant effect in reducing the EPSP responses (n=6; p<0.05 Wilcoxon rank
sum non-parametric). The mean value was not subtracted from experimental
conditions with pharmacological agents in the remaining results, but this effect
should be considered. Thus, exposure to 500µM and 1mM kainate produced a
significant difference from sham control, whereas 100µM did not (p<0.05
Student’s t-test).
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In examining the effects of the AMPA and kainate receptor agonist,
domoic acid (10μm and 1mM), the postsynaptic receptor sensitivity to
spontaneous quantal responses and the frequency of spontaneous events were
assessed. It was readily apparent that domoic acid at 1mM rapidly reduced the
amplitude of spontaneous mEPSP quantal events (Figure 2-3A) as well as the
frequency of occurrences (Figure 2-3B). Domoic acid at 10μM or 1 mM did not
produce an effect on the resting membrane potential (Figure 2-3C). Glutamate at
10mM produced similar effects in reducing the mEPSP amplitude and frequency
but this was compounded by the rapid depolarization that glutamate produced
(p<0.05; Figure 2-3C). The differences in the AMPA and kainate receptor agonist
and glutamate are that, domoic acid did not significantly depolarize the muscle;
however, the mEPSPs were still affected. The combination of domoic acid (1mM)
and glutamate (10mM) produced a reduced depolarization of the muscle and as
expected, a reduced mEPSP amplitude and frequency occurred (Figure 2-3B, C).
These results suggest domoic acid is an antagonist to the postsynaptic glutamate
receptors. The effect on the reduced frequency of the mEPSPs is due to the
gradual reduction in the mEPSP amplitude, such that they are not discernable
from noise in the baseline and thus are not detected to monitor their frequency.
Similar results were obtained for domoic acid as for kainate. The mEPSP
amplitudes and the frequency are reduced (Figure 2-4A, B). Also the resting
membrane potential is not significantly altered. In examining subtle effects on
single quantal events the shape of the quantal events were examined and
significant effects in rise time or decay were measured (data not shown). The
amplitude and area (i.e., area under the curve) of the mEPSPs both decreased in
a dose-dependent manner for 1mM and 500μM (Figure 2-4C). With exposure to
kainate, the smaller mEPSPs appeared to fade into the background noise while
the previously larger mEPSPs events were now observed as smaller mEPSPs.
Since the postsynaptic glutamate receptors on the muscle appear to bind
kainate, I expected the known agonist of kainate receptors, ATPA, to act similarly,
despite knowing that the receptors are not a kainate subtype. ATAP at 1mM did
not reduce the evoked EPSPs (Figure 2-5A, B) nor did ATPA have any effect on
the resting membrane potential (Figure 2-5C). In fact, some preparations
increased in the EPSP amplitude while others decreased, thus producing no net
significant effect.
If there are subtle effects of kainate in depressing presynaptic vesicular
docking or altering [Ca2+]i dynamics, one would expect that facilitation or the
short-term depression (i.e., negative facilitation) index might detect such an effect.
A short four pulse train of 20Hz produces the characteristic response known for
this preparation, as shown in Figure 2-6A. The initial EPSP is normally used as a
relative reference to the 4th EPSP in the train. It has been previously
demonstrated that 1mM [Ca2+]o will produce a marked depression in the
response train where as 500μM [Ca2+]o produces less depression and sometimes
a slight facilitation. Thus, both 1mM and 500μM [Ca2+]o were examined with 1mM
and 500μM kainate to unmask any ceiling effect in the depression by 1mM
[Ca2+]o exposure. The 1st and 4th EPSPs rapidly attenuate in amplitude upon
exposure to 1mM kainate and 0.5mM [Ca2+]o (Figure 2-6B). The EPSPs also
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show a large reduction to kainate when bathed with 1mM [Ca2+]o (Figure 2-6C).
However, no significant differences, by parametric analysis (Student’s t-test), in
the facilitation index are observed among the four conditions for exposure to
kainate as determined by the difference in the median FI values. The difference
is measured from saline to exposure of kainate within each preparation (n=5;
500μM kainate-1mM [Ca2+]o; 1mM kainate-1mM [Ca2+]o; 500μM kainate-500μM
[Ca2+]o; 1mM kainate-500μM [Ca2+]o; Figure 2-6D). If the effect to exposure of
kainate (1mM) with 1mM [Ca2+]o is analyzed by non-parametric statistics, then
five out five preparations showed an increase in the mean FI (p<0.05, Wilcoxon
Rank Sum). However, two preparations showed only small increases of 10 and
12 %. Thus, I do not feel confident in stating that there is a significant increase in
the mean FI with kainate by non-parametric analysis. On the other hand, boxwhisker plots of the FI values before and after exposure to kainate, for each
preparation, in the various paradigms revealed a trend again related to the same
data set of kainate (1mM) with 1mM [Ca2+]o (Figure 2-7). The box-whisker plots
represent the median, 25th, 75th, and range. One can observe that the variability
in the distributions is larger for the kainate (1mM) with 1mM [Ca2+]o as compared
to the same preparations before the exposure. In the other paradigms the
variability is about the same for saline and kainate exposure. To further examine
this variability in FI, the standard deviation for each preparation before and after
exposure to kainate was examined. Only the kainate (1mM) with 1mM [Ca2+]o
showed a consistent trend (five out of five; p<0.05, Wilcoxon Rank Sum Test;
also by Student’s t-test p<0.05) with an increase in the variability while exposed
to kainate as compared to the saline baseline. The changes in the individual
preparations for this paradigm are shown in Figure 2-8.
In order to further investigate possible presynaptic, metabotropic
glutamate receptor action on the motor nerve terminals, the common
metabotropic glutamate receptor agonist trans-1-aminocyclopentane-1, 3dicarboxylic acid (t-ACPD) was used. Potentially, an increase or a decrease in
the evoked EPSP would be possible at this insect NMJ since at the crayfish NMJ
(also an arthropod species) an effect was reported (Schramm and Dudel, 1997).
However, no significant alterations on evoked EPSPs amplitudes (Figure 2-9A,
B) or on the resting membrane potential of the muscle occurred during exposure
to t-ACPD (500μM) at the Drosophila NMJ. In comparison to the sham saline
control (Figure 2-2D), the distributions in EPSP amplitudes over lap; thus, the
slight reduction in EPSP amplitudes with t-ACPD are not significant.
Discussion
In this study I showed, in a concentration-dependant manner, that kainate
rapidly reduced the amplitude of evoked EPSPs as well as the spontaneous
quantal events. The lack in any response of t-ACPD and ATPA as well as a lack
in these compounds mimicking kainate’s action suggest that there is not a
presynaptic mechanism of a kainate-like or metabotropic autoreceptors on these
motor nerve terminals. However, the kainate receptor agonist, domoic acid, did
follow the actions of kainate in reducing the evoked EPSPs. I suggest this action
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is due to domoic acid and kainate acting as an antagonist on the postsynaptic
quisqualate receptors present on muscle and that no presynaptic contribution
can be proposed for the rapid reduced amplitude in the evoked EPSP and
quantal responses. The reduced frequency in the spontaneous quantal
responses in the presence of kainate or domoic acid appears to be due to the
responses decreasing in size to a point that they are not detectable from the
noise or that the postsynaptic receptors are fully blocked.
The responses observed at the crayfish NMJ by Schramm and Dudel
(1997) for analogous types of NMJs as I used in the Drosophila larval NMJ
(Atwood and Cooper, 1995, 1996) must be different in regards to presynaptic
autoreceptors. In their study, t-ACPD and glutamate itself produced varied
responses in mean quantal content. Some preparations they reported showed an
enhancement while others a decrease in evoked postsynaptic events. They
concluded that there may be differential regulation in the type and density of the
metabotropic presynaptic autoreceptors to account for variation among
preparations and effects to t-ACPD and glutamate. There are methodological
differences in stimulating the nerve terminals. In my studies, I elicited action
potentials within the nerve to result in Ca2+ influx and vesicular fusion. However,
Schramm and Dudel used depolarization pulses delivered over the terminal,
through the focal electrode, to directly open voltage-gated channels. Seal stability
with the focal electrode over the NMJ, longer than normal action potential
depolarization pulses and tweaking the current pulses to a fine degree in order to
balance a percentage of activating voltage dependent ion channels, would
appear to induce potentially more experimental variability among preparations
than inducing a standard action potential within the nerve for evoking synaptic
transmission. The large field effect of a current pulse, to induce presynaptic
depolarization, through a macropatch electrode could have an effect on the
postsynaptic glutamate receptors such that the receptor interaction with
pharmacological agents of even glutamate itself might be altered. To resolve
these issues in the crayfish would require selectively stimulating the motor nerve
and repeating the study.
As for domoic acid, the results suggest kainate is an antagonist to the
postsynaptic glutamate receptors in a dose-dependent manner. It appears
kainate can behave as an antagonist but not ATPA for these postsynaptic muscle
receptors. In addition, since ATPA did not produce any significant alteration in
the evoked EPSP amplitude, there does not appear to be any pre- or postsynaptic action of ATPA. Quisqualate has been suggested to activate ionotropic
as well as metabotropic glutamate receptors just as glutamate does itself, which
suggests quisqualate is a non-selective glutamate receptor agonist (Schoepp et
al., 1990). However, AMPA, which is significantly similar to quisqualate in
structure and is a weak kainate receptor agonist, cannot activate nor even bind to
homomeric GluR6 kainate receptor (Egebjerg et al., 1991). Such differences may
be induced by steric hindrance near the ligand binding domain. In fact, AMPA did
not change the EPSP amplitude in my studies, but kainate resulted in reduced
amplitude by acting as an antagonist. Therefore, there seems to be other factors
besides steric hindrance. It would seem likely that a ligand binding site of kainate
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at the Drosophila NMJ would be highly conserved to the vertebrate kainate
receptor, since kainate is blocking evoked responses; however, the similarity of
extracellular domains are not very high. Recent studies suggested that the
properties of ionotropic glutamate receptor subunits can be changed by mutating
the amino acid at the second transmembrane segment which forms the lining of
the pore region (Bochet et al., 1991; Curutchet et al., 1992; Verdoorn et al.,
1991). For the functional muscle-expressed glutamate receptor GluR-IIC, GluRIID, GluR-IIE and either GluR-IIA or GluR-IIB is essential for function. Therefore,
only based on the ligand binding domain tetrameric structure was suggested.
The correct subunit stoichiometry is not known. The receptor can be pentameric
or higher such as (IIA)(IIB)(IIC)(IID)(IIE) or (IIA)(IIA)(IIC)(IID)(IIE) to be functional.
Also, glutamate receptor complexes which contain either GluR-IIA or GluR-IIB
have opposite physiological properties by showing slow and fast desensitization,
respectively (DiAntonio et al., 1999). Thus, as constituted receptor subunits are
put together it is likely that the receptor is functionally changed. There could also
be mixed subunit combinations along the nerve terminal among the many
synaptic sites, since the terminal is developmental different in age along its
length (Atwood and Cooper, 1995; He et al., 2009; Li et al., 2002) and function
(Bogdanik et al., 2004; Guerrero et al., 2005; Marrus et al., 2004; Liebl and
Featherstone, 2005;). Developmental alteration in kainate receptors are known
in vertebrates (Lee et al., 2001). Thus, variability in whole muscle responses to
pharmacological agents might be masked, but if older and younger regions of the
terminals were monitored with focal macropatch electrodes larger differences in
the pharmacological profiles and sensitivities might be observed.
It was proposed that the five subunits consisting of postsynaptic receptors
in Drosophila NMJ are somewhat similar in homology to kainate receptors in
vertebrates and thus, they were termed kainate-like (Betz et al., 1993; Guerrero
et al., 2005; Marrus et al., 2004; Qin et al., 2005; Völkner et al., 2000). In
comparing the postsynaptic receptor molecular sequence of Drosophila NMJ with
a kainate receptor in Homo sapiens, which contains the highest homology in the
vertebrates, each subunit shows a moderate similarity between two species.
Extracellular domains of the receptors are not significantly higher in similarity
compared to total sequence (Figure 2-10). In a phylogeny tree with 36
glutamate receptor protein sequences in Drosophila melanogaster and human’s
NMDA, kainate and AMPA receptors, the five subunits of postsynaptic receptors
in Drosophila NMJ appear to be in a different subgroup to even the closest of the
vertebrate kainate/AMPA type receptors (Figure 2-11).
There are multiple examples of pre- and/or post-synaptic action of kainate
in enhancing or suppressing synaptic transmission in vertebrate neuronal circuits
(Grabauskas et al., 2007; Hegarty et al., 2007; Kamiya and Ozawa, 2000;
Pinheiro and Mulle, 2008; Rozas et al., 2003; Schoepp, 2002); and it has been
reported earlier that kainate blocked synaptic transmission at the Drosophila NMJ
(Chang and Kidokoro, 1996; McLarnon and Quastel, 1988). However, the earlier
studies with Drosophila did use Schneider’s Drosophila medium which is known
to have a depressing action on synaptic transmission itself (Ball et al., 2003;
Stewart et al., 1994). Mechanistically I do not know how kainate is blocking
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transmission, but it appears likely that kainate acts as an antagonist in this
preparation. Possible kainate could act on the receptor to desensitize it to
glutamate or in addition act as a non-competitive antagonist. Quisqualate
receptors are known to be prone to desensitization at the crayfish NMJ (Tour et
al., 2000) as well as other glutamate receptors (Sun et al., 2002).
The results with kainate at different concentrations and the two
concentrations of bathing [Ca2+]o is interesting since only the one condition of
1mM kainate and 1mM [Ca2+]o produced a significant trend in both an increase in
the median FI value as well variability in the responses as compared to baseline
saline exposure (Figures 2-7 and 2-8). As stated earlier the increase in median
values is small in some preparations so I am cautious in bearing too much
emphasis on this result; however, the increase in variability when exposed to
kainate is of interest. If kainate is acting as a competitive antagonist then it is
feasible to speculate with each pulse in the stimulus train the glutamate is
resulting in a greater displacement of the kainate and possibly resulting in more
competitive-competition. As the glutamate is being taken back up in the nerve
terminal by the glutamate transporters, kainate’s action can dominate producing
very variable responses on the amplitudes of the EPSPs throughout the four
pulse train. Considering when saline is exchanged for saline containing kainate,
the 1st EPSP within the train is dampened significantly by the antagonistic action
and during the evoked release of glutamate then the kainate is displaced would
possible explain the slight, but consistent, increase in the median FI values as
well for this experimental paradigm. This also follows for the concept that when
the [Ca2+]o is reduced to 0.5mM, the evoked amount of glutamate is not as
pronounced so less displacement of the kainate would occur, which might
explain why there is not as change on FI or on the median as well as the
variability in the FI (Figure 2-7). I am not aware of reports addressing
pharmacological examination of competitive antagonists during pulse trains to
account for fluctuation in facilitation measures to compare my findings. More
studies are warranted to examine this tentative working model in competitive
antagonism during synaptic facilitation/depression to explain the mechanistic
details behind these findings.
Since I have not been able to detect any presynaptic autoreceptor function
at these NMJs, it would be interesting to know if these motor neurons produce
mRNA for any glutamate receptor subtype. There has yet to be investigation of
possible presynaptic actions at other NMJs in the larvae or adult of Drosophila.
The subset of junctions that I examined may not be indicative of all the
Drosophila NMJs, so further investigations are warranted.
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Figure 2-1: The dissected 3rd instar Drosophila larva preparation. (A) The
preparation is pinned at the four corners to keep the preparation
taut. The ventral abdominal muscle m6 is used in this study. The
segmental nerves are stimulated by placing the nerve into a suction
electrode and recruiting the Is and Ib motor neurons. (B) The
terminals of Ib and Is on m6 and m7 are readily observed after
treatment with fluorescently tagged anti-HRP antibody (Scale:
50μm). (C) Elicited excitatory postsynaptic potentials (EPSPs) in
m6 are measured with an intracellular recording. Representative
individual responses from the Ib and Is motor axons as well as the
composite Ib and Is response are shown for a early 3rd instar.
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Figure 2-2: The effect of kainate on the evoked EPSP amplitudes. (A)
Application of 1mM kainate reduces the EPSP rapidly and the
effect can be partially washed out. (B) The dose-response effect in
damping the EPSP amplitude. For all concentrations of kainate the
EPSP amplitudes are reduced. (C) The dose-response effects on
the resting membrane potential for m6. The resting membrane
potentials do not appear to be changed. With the maintaining
resting membrane potential, reduced EPSP amplitudes are induced
by the antagonistic action of kainate. (D) Sham control for
exchanging the saline bath and time revealed a 13.5% reduction in
the EPSP amplitude. When compared to sham control, both 500μM
and 1mM still show significantly reduced EPSPs (around 46%
decrease)
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Figure 2-3: Effects of domoic acid (agonist for AMPA and kainate receptors) at
the NMJ. Domoic acid is a potent kainate receptor agonist. (A)
Spontaneous or mEPSPs (miniature EPSPs) are reduced in
amplitude upon exposure to 1mM of domoic acid. With washing out
the domoic acid, the spontaneous responses gradually come up
again. (B) The frequency of mEPSPs is reduced by domoic acid in
a dose-dependent manner. Glutamate mimics the effect. (C)
Domoic acid did not produce a consistent effect on the resting
membrane potential; however glutamate produced a drastic
depolarization fitting for agonistic action. Domoic acid attenuates
the effect of glutamate on membrane depolarization. So, domoic
acid appears to be blocking the glutamate action on the muscle.

72

Figure 2-4: Effects of kainate (1 and 0.5 mM) on mEPSPs properties. (A)
Spontaneous or mEPSPs (miniature EPSPs) are reduced in
amplitude upon exposure. (B) The frequency of mEPSPs is
reduced by domoic acid in a dose-dependent manner, as well as
the (C) amplitude and area of the mEPSPs. Kainate seems to be
acting presynaptically as well as postsynaptically. However, the
problem of this measuring is that the mEPSPs can be buried within
the noise as the amplitude of mEPSPs are reduced.
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Figure 2-5: Effects of ATPA (1 mM; a selective agonist of vertebrate GluR5, kainate
receptors) on the amplitude of evoked EPSPs (A), (B) as well as the
resting membrane potential of the muscle (C). ATPA does not
appear to alter the EPSP amplitude or the resting membrane
potential.
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Figure 2-6: Effects of kainate on short-term depression (i.e., negative
facilitation) with varied [Ca2+]o. (A) A four pulse stimulus train
delivered at 20Hz results in an initial large EPSP followed by
depressed responses. The procedure for measuring EPSP
amplitudes is indicated. Facilitation index (FI) is then calculated
from these measures. (B) A typical response for the effect of
kainate (KA; 1 mM) on the pulse train in the presence of 0.5 mM
[Ca2+]o. (C) A typical response for the effect of KA (1 mM) on the
pulse train in the presence of 1 mM [Ca2+]o. (D) The difference in
facilitation index (FI) is shown for both 1mM and 0.5mM KA with
either 1mM or 0.5mM [Ca2+]o. The differences in the median values
are obtained from the difference in FI saline to exposure of KA
within each preparation. (n=5 for each paradigm; * p<0.05
Wilcoxon Rank Sum Test for the effect of KA as compared to
saline).
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Figure 2-7: Effects of kainate (KA) and calcium on FI. Box and whisker plots for
FI in various conditions are shown as before and after exposure to
kainate, for each of the five preparations in the four experimental
conditions. The plots show the median, 25th, 75th percentiles and
range. In almost all preparations, median values of FI index seem
to be the same before and after exposure to kainate. So, kainate
does not appear to have a presynaptic action. With 1mM Ca2+ and
1mM kainate, both median and variation of FI index are increased
in five out of five preparations after exposure to kainate. However,
after changing the [kainate] into 0.5mM, neither median nor
variation of facilitation index shows a consistent increase in values.
So, kainate seems to be acting as a competitive antagonist.
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Figure 2-8: The standard deviation (SD) for each preparation before and during
exposure to kainate (1mM) with 1mM [Ca2+]o produced a consistent
trend in increasing in the variability among the data sets while
exposed to kainate (KA) as compared the saline (S) baseline
(p<0.05, Wilcoxon Rank Sum Test; also p<0.5 Student’s t-test).
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Figure 2-9: Action of t-ACPD on evoked EPSPs and resting membrane
potential. (A) Evoked EPSPs in saline and during exposures to tACPD (50 μM). (B) The mean percent change in the amplitude of
the evoked EPSPs with exposure to t-ACPD. (C) The mean percent
change in the resting membrane potential with exposure to t-ACPD.
t-ACPD does not appear to have an action on the postsynaptic
muscle or the glutamate receptors.
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Figure 2-10: Sequence comparison of five postsynaptic receptor subunits
identified from Drosophila muscle mRNA to the five known human
kainate receptor subunits. Each two sequences were compared by
using a blastP alignment. The top bar is a comparison for the total
protein sequence. The bottom bar is a comparison of the putative
extracellular domains among the proteins. The gray area is the
percentage of identical sequence and the white are is the percent in
similarity based on the blastP (NCBI) algorithm. The five human
receptor subunits used are: (A) GluR5; (B) GluR6; (C) GluR7; (D)
KA1; and (E) KA2.

Figure 2-11: Phylogeny tree comparing all known putative 36 ionotropic
glutamate receptor subunits in the Drosophila genome with human
glutamate receptors (kainate receptor subunits GluR5, GluR6 and
KA2; AMPA receptor subunit GluR1; NMDA receptor subunits NR-1
and NR-2). The comparison was performed by ClustalW2 (EMBLEBI).
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